US20210079438A1 - Carbohydrate esters as inducers for gene expression - Google Patents
Carbohydrate esters as inducers for gene expression Download PDFInfo
- Publication number
- US20210079438A1 US20210079438A1 US17/100,496 US202017100496A US2021079438A1 US 20210079438 A1 US20210079438 A1 US 20210079438A1 US 202017100496 A US202017100496 A US 202017100496A US 2021079438 A1 US2021079438 A1 US 2021079438A1
- Authority
- US
- United States
- Prior art keywords
- vinyl
- sophorose
- formula
- acid
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Carbohydrate esters Chemical class 0.000 title claims abstract description 113
- 239000000411 inducer Substances 0.000 title claims description 74
- 230000014509 gene expression Effects 0.000 title abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 121
- 238000000855 fermentation Methods 0.000 claims abstract description 61
- 230000004151 fermentation Effects 0.000 claims abstract description 61
- 150000001875 compounds Chemical class 0.000 claims abstract description 54
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 claims description 136
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 claims description 136
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 116
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 claims description 106
- 239000000203 mixture Substances 0.000 claims description 101
- ZTOKUMPYMPKCFX-CZNUEWPDSA-N (E)-17-[(2R,3R,4S,5S,6R)-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxyoctadec-9-enoic acid Chemical compound OC(=O)CCCCCCC/C=C/CCCCCCC(C)O[C@@H]1O[C@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O1 ZTOKUMPYMPKCFX-CZNUEWPDSA-N 0.000 claims description 75
- 229910052739 hydrogen Inorganic materials 0.000 claims description 69
- 108090000623 proteins and genes Proteins 0.000 claims description 61
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 58
- 235000019253 formic acid Nutrition 0.000 claims description 58
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 57
- 102000004169 proteins and genes Human genes 0.000 claims description 55
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 52
- 229910052799 carbon Inorganic materials 0.000 claims description 51
- 238000004519 manufacturing process Methods 0.000 claims description 51
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 48
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 46
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 46
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 44
- 239000008101 lactose Substances 0.000 claims description 44
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 42
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- 241000223259 Trichoderma Species 0.000 claims description 42
- 108010059892 Cellulase Proteins 0.000 claims description 39
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 35
- 229940106157 cellulase Drugs 0.000 claims description 34
- 125000001931 aliphatic group Chemical group 0.000 claims description 32
- 239000008103 glucose Substances 0.000 claims description 32
- 125000006686 (C1-C24) alkyl group Chemical group 0.000 claims description 30
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 30
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 30
- 238000010306 acid treatment Methods 0.000 claims description 30
- 241001278026 Starmerella bombicola Species 0.000 claims description 29
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 28
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 28
- 239000000758 substrate Substances 0.000 claims description 25
- 108010065511 Amylases Proteins 0.000 claims description 22
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 21
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 20
- 239000004382 Amylase Substances 0.000 claims description 20
- 102000013142 Amylases Human genes 0.000 claims description 20
- 241000228212 Aspergillus Species 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 235000019418 amylase Nutrition 0.000 claims description 20
- 229940088598 enzyme Drugs 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 18
- 229920002678 cellulose Polymers 0.000 claims description 18
- 239000001913 cellulose Substances 0.000 claims description 18
- 229920001567 vinyl ester resin Polymers 0.000 claims description 18
- 150000002016 disaccharides Chemical class 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 17
- 239000007787 solid Substances 0.000 claims description 17
- 229920002472 Starch Polymers 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 16
- 239000008107 starch Substances 0.000 claims description 16
- 235000019698 starch Nutrition 0.000 claims description 16
- 238000005809 transesterification reaction Methods 0.000 claims description 16
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 241000233866 Fungi Species 0.000 claims description 13
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 13
- 229910001868 water Inorganic materials 0.000 claims description 13
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 claims description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 241000499912 Trichoderma reesei Species 0.000 claims description 12
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 12
- 235000019202 steviosides Nutrition 0.000 claims description 12
- 150000004675 formic acid derivatives Chemical class 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims description 10
- 108090001060 Lipase Proteins 0.000 claims description 10
- 102000004882 Lipase Human genes 0.000 claims description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 239000011541 reaction mixture Substances 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- 229920002774 Maltodextrin Polymers 0.000 claims description 9
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 9
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 9
- 241000228245 Aspergillus niger Species 0.000 claims description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical group [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 229940049918 linoleate Drugs 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 7
- 108010048733 Lipozyme Proteins 0.000 claims description 7
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 7
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 claims description 7
- 239000002028 Biomass Substances 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- UJRIYYLGNDXVTA-UHFFFAOYSA-N ethenyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC=C UJRIYYLGNDXVTA-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000002798 polar solvent Substances 0.000 claims description 6
- 229920002554 vinyl polymer Polymers 0.000 claims description 6
- 101150108358 GLAA gene Proteins 0.000 claims description 5
- 241000228143 Penicillium Species 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 101150052795 cbh-1 gene Proteins 0.000 claims description 5
- WGXGKXTZIQFQFO-CMDGGOBGSA-N ethenyl (e)-3-phenylprop-2-enoate Chemical compound C=COC(=O)\C=C\C1=CC=CC=C1 WGXGKXTZIQFQFO-CMDGGOBGSA-N 0.000 claims description 5
- LPUZTLKYAOOFDX-QXMHVHEDSA-N ethenyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC=C LPUZTLKYAOOFDX-QXMHVHEDSA-N 0.000 claims description 5
- FFYWKOUKJFCBAM-UHFFFAOYSA-N ethenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC=C FFYWKOUKJFCBAM-UHFFFAOYSA-N 0.000 claims description 5
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 claims description 5
- AFSIMBWBBOJPJG-UHFFFAOYSA-N ethenyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC=C AFSIMBWBBOJPJG-UHFFFAOYSA-N 0.000 claims description 5
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 101100162670 Bacillus subtilis (strain 168) amyE gene Proteins 0.000 claims description 4
- 241000186321 Cellulomonas Species 0.000 claims description 4
- 241000223218 Fusarium Species 0.000 claims description 4
- 241000223198 Humicola Species 0.000 claims description 4
- 239000004367 Lipase Substances 0.000 claims description 4
- 241000222350 Pleurotus Species 0.000 claims description 4
- 241000187747 Streptomyces Species 0.000 claims description 4
- 241000228341 Talaromyces Species 0.000 claims description 4
- 241000203640 Thermomonospora Species 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 101150069712 amyA gene Proteins 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 4
- 235000019421 lipase Nutrition 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000005292 vacuum distillation Methods 0.000 claims description 4
- 241001578974 Achlya <moth> Species 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000221198 Basidiomycota Species 0.000 claims description 3
- 241001619326 Cephalosporium Species 0.000 claims description 3
- 241000228437 Cochliobolus Species 0.000 claims description 3
- 102000004127 Cytokines Human genes 0.000 claims description 3
- 108090000695 Cytokines Proteins 0.000 claims description 3
- 241001246273 Endothia Species 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 241000235395 Mucor Species 0.000 claims description 3
- 241000221960 Neurospora Species 0.000 claims description 3
- 108010084311 Novozyme 435 Proteins 0.000 claims description 3
- 241001523629 Pestalotiopsis Species 0.000 claims description 3
- 241000221945 Podospora Species 0.000 claims description 3
- 241000231139 Pyricularia Species 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 229930003935 flavonoid Natural products 0.000 claims description 3
- 150000002215 flavonoids Chemical class 0.000 claims description 3
- 235000017173 flavonoids Nutrition 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 238000009630 liquid culture Methods 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 229910000069 nitrogen hydride Inorganic materials 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 2
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 230000006698 induction Effects 0.000 abstract description 72
- 238000002360 preparation method Methods 0.000 abstract description 11
- 239000012092 media component Substances 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract 2
- 235000014633 carbohydrates Nutrition 0.000 description 33
- 230000000694 effects Effects 0.000 description 26
- 230000001939 inductive effect Effects 0.000 description 24
- JRQOTZAJQMBWJY-RJMJUYIDSA-N acetic acid (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical class CC(O)=O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)C(O)O[C@@H]1CO JRQOTZAJQMBWJY-RJMJUYIDSA-N 0.000 description 23
- 150000003396 sophoroses Chemical class 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 19
- 150000002148 esters Chemical class 0.000 description 19
- 238000003776 cleavage reaction Methods 0.000 description 18
- 230000007017 scission Effects 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 125000003342 alkenyl group Chemical group 0.000 description 14
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 description 13
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 13
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 12
- 239000000539 dimer Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 10
- 239000000828 canola oil Substances 0.000 description 10
- 235000019519 canola oil Nutrition 0.000 description 10
- 229940013618 stevioside Drugs 0.000 description 10
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 10
- 230000014616 translation Effects 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 9
- 239000007790 solid phase Substances 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 235000019439 ethyl acetate Nutrition 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000003262 industrial enzyme Substances 0.000 description 6
- 150000002597 lactoses Chemical class 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 150000002191 fatty alcohols Chemical class 0.000 description 5
- 239000001965 potato dextrose agar Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000003643 water by type Substances 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 238000005852 acetolysis reaction Methods 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 125000005313 fatty acid group Chemical group 0.000 description 4
- 125000001924 fatty-acyl group Chemical group 0.000 description 4
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 description 4
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 229940049964 oleate Drugs 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 0 *C(=O)O[C@@H]1C(CC)O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@H]1O.C.CCC1OC(C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)*O[C@@H]3OC(CC)[C@@H](O)[C@H](O)C3O[C@@H]3OC(CC)[C@@H](O)[C@H](O)C3O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](OCC2OC(C)C(O)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1[Rb]O Chemical compound *C(=O)O[C@@H]1C(CC)O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@H]1O.C.CCC1OC(C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)*O[C@@H]3OC(CC)[C@@H](O)[C@H](O)C3O[C@@H]3OC(CC)[C@@H](O)[C@H](O)C3O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](OCC2OC(C)C(O)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1[Rb]O 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- TWWXLEVEBAQOGF-KAUKMZENSA-N CCC1O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1C Chemical compound CCC1O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1C TWWXLEVEBAQOGF-KAUKMZENSA-N 0.000 description 3
- 230000003190 augmentative effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 3
- 239000006151 minimal media Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 125000005017 substituted alkenyl group Chemical group 0.000 description 3
- 125000000547 substituted alkyl group Chemical group 0.000 description 3
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical class CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 235000015099 wheat brans Nutrition 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 2
- 240000000385 Brassica napus var. napus Species 0.000 description 2
- FIAIJNMCCCZNPV-SNIPBWSTSA-N C.CC(=O)OCC1O[C@@H](O[C@@H]2C(CO)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](O)C(O[C@@H]2OC(COC(C)=O)[C@@H](O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](OCC2OC(C)C(O)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1O.CCC1O[C@H](C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCC(O)CCCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCCC(O)CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](O)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCC/C=C/CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCCCCC(C=CCCCCCCCC(=O)O[C@@H]1C(CC)O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@H]1O)C(C)O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O Chemical compound C.CC(=O)OCC1O[C@@H](O[C@@H]2C(CO)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](O)C(O[C@@H]2OC(COC(C)=O)[C@@H](O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](OCC2OC(C)C(O)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1O.CCC1O[C@H](C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCC(O)CCCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCCC(O)CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](O)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCC/C=C/CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCCCCC(C=CCCCCCCCC(=O)O[C@@H]1C(CC)O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@H]1O)C(C)O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O FIAIJNMCCCZNPV-SNIPBWSTSA-N 0.000 description 2
- RJGBMKBIMFTHLX-KJSZPUKUSA-N CCC1OC(C)C(O)[C@@H](O)[C@@H]1O[C@@H]1OC(CC)[C@H](C)[C@H](O)C1O.CCC1O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C Chemical compound CCC1OC(C)C(O)[C@@H](O)[C@@H]1O[C@@H]1OC(CC)[C@H](C)[C@H](O)C1O.CCC1O[C@@H](OC2C(C)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(C)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C RJGBMKBIMFTHLX-KJSZPUKUSA-N 0.000 description 2
- 108010084185 Cellulases Proteins 0.000 description 2
- 102000005575 Cellulases Human genes 0.000 description 2
- 241001674013 Chrysosporium lucknowense Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 229910005390 FeSO4-7H2O Inorganic materials 0.000 description 2
- 229910005444 FeSO4—7H2O Inorganic materials 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- 229910017621 MgSO4-7H2O Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241001540751 Talaromyces ruber Species 0.000 description 2
- 241001313536 Thermothelomyces thermophila Species 0.000 description 2
- 241000452385 Trichoderma reesei RUT C-30 Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241001149679 [Candida] apicola Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 125000004450 alkenylene group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000002551 biofuel Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000001925 catabolic effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 150000002190 fatty acyls Chemical group 0.000 description 2
- VGGRCVDNFAQIKO-UHFFFAOYSA-N formic anhydride Chemical compound O=COC=O VGGRCVDNFAQIKO-UHFFFAOYSA-N 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 150000002525 isomaltoses Chemical class 0.000 description 2
- 150000002596 lactones Chemical group 0.000 description 2
- 150000002692 maltoses Chemical class 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 125000003152 sophorose group Chemical group 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- UMIZOHMCQYCZRX-IHWYPQMZSA-N (9Z)-17-hydroxyoctadec-9-enoic acid Chemical class CC(O)CCCCCC\C=C/CCCCCCCC(O)=O UMIZOHMCQYCZRX-IHWYPQMZSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- FTEYMUPEVIPIHM-GTDRIFFSSA-N C(C)(=O)O.C(C)(=O)O.OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO Chemical compound C(C)(=O)O.C(C)(=O)O.OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO FTEYMUPEVIPIHM-GTDRIFFSSA-N 0.000 description 1
- SKFVAWFLRMCXAD-LQFHVJOCSA-N C.CC(=O)OCC1O[C@@H](O[C@@H]2C(CO)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](O)C(O[C@@H]2OC(COC(C)=O)[C@@H](O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](OCC2OC(O)C(O)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1O.CCC1O[C@H](C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCCC(O)CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](O)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCC/C=C/CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](O)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCC(O)CCCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCCCCC(C=CCCCCCCCC(=O)O[C@@H]1C(CC)O[C@@H](OC2C(O)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@H]1O)C(C)O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O Chemical compound C.CC(=O)OCC1O[C@@H](O[C@@H]2C(CO)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@@H](O[C@@H]2C(COC(C)=O)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](O)C(O[C@@H]2OC(COC(C)=O)[C@@H](O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CC(=O)OCC1O[C@H](OCC2OC(O)C(O)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1O.CCC1O[C@H](C)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCCC(O)CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](O)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCC/C=C/CCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCC1O[C@H](O)C(O[C@@H]2OC(CC)[C@@H](OC(=O)CCCCCCCC(O)CCCCCCCC(C)O)[C@H](O)C2O)[C@@H](O)[C@@H]1O.CCCCCC(C=CCCCCCCCC(=O)O[C@@H]1C(CC)O[C@@H](OC2C(O)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@H]1O)C(C)O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O[C@@H]1OC(CC)[C@@H](O)[C@H](O)C1O SKFVAWFLRMCXAD-LQFHVJOCSA-N 0.000 description 1
- VNBHHNFXMDBWDC-NSCMZPSISA-N CCC1OC(O)C(O)[C@@H](O)[C@@H]1O[C@@H]1OC(CC)[C@H](C)[C@H](O)C1O.CCC1O[C@@H](OC2C(O)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C Chemical compound CCC1OC(O)C(O)[C@@H](O)[C@@H]1O[C@@H]1OC(CC)[C@H](C)[C@H](O)C1O.CCC1O[C@@H](OC2C(O)OC(CC)[C@@H](O)[C@@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C.CCC1O[C@@H](O[C@@H]2C(CC)OC(O)C(O)[C@H]2O)C(O)[C@@H](O)[C@@H]1C VNBHHNFXMDBWDC-NSCMZPSISA-N 0.000 description 1
- 108010031797 Candida antarctica lipase B Proteins 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 229920002299 Cellodextrin Polymers 0.000 description 1
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000123346 Chrysosporium Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 102000003849 Cytochrome P450 Human genes 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 101710158368 Extracellular lipase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910017234 MnSO4 H2O Inorganic materials 0.000 description 1
- 229910017237 MnSO4-H2O Inorganic materials 0.000 description 1
- 229910017228 MnSO4—H2O Inorganic materials 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000985535 Penicillium decumbens Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000959173 Rasamsonia emersonii Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 241001278052 Starmerella Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- XZAGBDSOKNXTDT-UHFFFAOYSA-N Sucrose monopalmitate Chemical compound CCCCCCCCCCCCCCCC(O)=O.OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(CO)O1 XZAGBDSOKNXTDT-UHFFFAOYSA-N 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 241001136494 Talaromyces funiculosus Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 101710128940 Triacylglycerol lipase Proteins 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000193624 Wickerhamiella Species 0.000 description 1
- 108700040099 Xylose isomerases Proteins 0.000 description 1
- WOTQVEKSRLZRSX-HYSGBLIFSA-N [(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1O[C@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1 WOTQVEKSRLZRSX-HYSGBLIFSA-N 0.000 description 1
- 241000966650 [Candida] riodocensis Species 0.000 description 1
- 241000192286 [Candida] stellata Species 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000001263 acyl chlorides Chemical group 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- WOTQVEKSRLZRSX-UHFFFAOYSA-N beta-D-cellobioside octaacetate Natural products CC(=O)OCC1OC(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(COC(C)=O)O1 WOTQVEKSRLZRSX-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011090 industrial biotechnology method and process Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000007273 lactonization reaction Methods 0.000 description 1
- QIGJYVCQYDKYDW-LCOYTZNXSA-N laminarabiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-LCOYTZNXSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 235000021084 monounsaturated fats Nutrition 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- VOCBWIIFXDYGNZ-IXKNJLPQSA-N testosterone enanthate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC2 VOCBWIIFXDYGNZ-IXKNJLPQSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Definitions
- the present invention relates to chemical compounds and methods of their preparation for use as inducers of gene expression in cell culturing. More particularly, this invention is related to the development of low cost and highly efficient protein inducers that significantly lower the manufacturing cost for enzyme manufacturers.
- Maltose, isomaltose, and maltodextrins are commonly used as soluble inducers for the induction of alpha-amylase and glucoamylase enzymes in Aspergillus spp. (Barton et al., J. Bacteriol ., b(3):771-777 (1972)), while sophorose, cellobiose, and lactose are three effective soluble inducers widely used in the industry for enzyme production in Trichoderma spp. (Kubicek et al., Biotech. Biofuels, 2:19 (2009)).
- Sophorose a beta 1, 2-disaccharide, is considered to be the most powerful inducer of the cellulase gene promoter in Trichoderma reesei , being 2500 times as active as cellobiose (Mandels et al., J. Bacteriol., 83(2):400-408 (1962)).
- These respective soluble inducers are all metabolized by Aspergillus or Trichoderma before, during, or after induction. Therefore, they are not considered as gratuitous inducers, thus requiring them to be continually supplied during the fermentation in order to achieve optimum induction.
- soluble inducers are typically supplied to the fermenter in a fed batch either alone or supplemented with alternative carbon sources such as glucose in a carbon-limited fashion. Due to the inducers being non-gratuitous, the induction process, if not fully optimized, will typically cause catabolic repression that significantly lowers the productivity, along with unnecessary growth that significantly lowers the yield. Thus, there exists a need in the art for a stronger, gratuitous, or nearly gratuitous inducer that decouples induction from unintended repression, growth, or other physiological functions, allowing more rigorous process optimization to significantly improve productivity and yield than is currently possible.
- a more powerful inducer can also be easily used to supply the induction needs of cheaper and non-inductive feedstocks as well as to enhance the induction of conventional inducers such as lactose, cellulose, maltodextrins, or cheaper alternatives such as starch and cellulose hydrolysates, and also in alternative production processes such as solid-phase fermentations.
- conventional inducers such as lactose, cellulose, maltodextrins, or cheaper alternatives such as starch and cellulose hydrolysates, and also in alternative production processes such as solid-phase fermentations.
- carbohydrate-based inducers are both inducers and repressors for protein expression
- methods to enhance the induction power by modifying the inducer to slow its uptake or metabolization are known.
- Hydrolysis products of cellobiose octaacetate although not characterized, are known to carry superior induction power than cellobiose (Mandels and Reese, J. Bacteriol., 79(6):816-826 (1960)).
- Sucrose monopalmitate induced a sucrase yield that is 80 times that of sucrose in Pullularia pullulans (Reese et al., J. Bacteriol., 100(3):1151-1154 (1969)).
- the present invention provides a method for producing a protein of interest comprising providing a fermentation host and culturing the fermentation host with a carbon source and one or more compounds selected from the group consisting of:
- R a is H or C(O)R
- R b is H or C(O)R
- R c is H or C(O)R
- R d is H or C(O)CH 3 ;
- R e is H or C(O)CH 3 ;
- R f is H or C(O)CH 3 ;
- R g is H or C(O)CH 3 ;
- R is an aliphatic moiety, with the proviso that in formula (II), R c is H when R a is H or C(O)CH 3 and R b is H or C(O)CH 3 , wherein the fermentation host is cultured under conditions sufficient to produce a protein of interest.
- the protein of interest is cellulase or amylase.
- the protein of interest is a homologous or heterologous protein.
- the homologous or heterologous protein is an enzyme, a hormone, a growth factor, a cytokine or an antibody.
- the fermentation host is capable of producing cellulase or amylase.
- the fermentation host is a filamentous fungus or bacteria or other hosts selected from the genus group consisting of Trichoderma, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces, Thermomonospora, Bacillus, Cellulomonas, Penicillium, Basidiomycete, Chrysoporium, Pestalotiopsis, Neurospora, Cephalosporium, Achlya, Podospora, Endothia, Mucor, Cochliobolus, Myceliopthora, Talaromyces , and Pyricularia .
- a filamentous fungus or bacteria or other hosts selected from the genus group consisting of Trichoderma, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces, Thermomonospora, Bacillus, Cellulomonas, Penicillium, Basidiomycete, Chrysoporium, Pestalot
- the fermentation host is the filamentous fungus Trichoderma reesei or Aspergillus niger .
- the fermentation host is grown in a liquid culture or on a solid substrate without free-flowing liquid.
- the fermentation host has a promoter operably linked to a gene encoding a protein of interest.
- the promoter is a cellulase gene promoter or an amylase gene promoter.
- the promoter is a cbh1 promoter or a glaA promoter or an amyA promoter.
- the carbon source is biomass.
- the biomass is glucose, sucrose, fructose, glycerol, lactose, cellulose, cellulose hydrolysate, starch, starch hydrolysate, maltose, or maltodextrin.
- the compound of formula (I), (II), (III), (IV) and (V) is isolated from a crude product mixture from either a chemical or enzymatically catalyzed trans-esterification reaction.
- the compounds of formula (VI) are isolated from formic acid treatment process of natural lactonic sophorolipid.
- the compounds of formula (VII) are isolated from the culture of the yeast Candida bombicola .
- R is an aliphatic moiety selected from unsubstituted C 1 -C 24 alkyl, substituted C 1 -C 24 alkyl, unsubstituted C 2 -C 24 alkenyl, and substituted C 2 -C 24 alkenyl.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with hydroxyl groups and C 2 -C 24 alkenyl substituted with hydroxyl groups.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with carboxyl groups and C 2 -C 24 alkenyl substituted with carboxyl groups.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with aromatic groups and C 2 -C 24 alkenyl substituted with aromatic groups.
- the compound of formula (I), (II), (III), (IV), (V), (VI), and (VII) comprises:
- R d is H or C(O)CH 3 ;
- R e is H or C(O)CH 3 ;
- R f is H or C(O)CH 3 ;
- R g is H or C(O)CH 3 .
- the present invention provides a method for producing one or more compounds of formula (I), formula (II), formula (III), formula (IV) or formula (V) comprising providing a disaccharide; and contacting the disaccharide with a vinyl ester in the presence of a lipase enzyme in a solvent system.
- the disaccharide comprises lactose, sophorose, cellobiose, maltose, or isomaltose.
- the lipase enzyme comprises Novozyme 435, Lipozyme TL, Lipozyme RM, or Amano lipase PS.
- the vinyl ester comprises vinyl acetate, vinyl propionate, vinyl butyrate, vinyl cinnamate, vinyl methacrylate, vinyl oleate, vinyl linoleate, vinyl palmitate, or vinyl stearate.
- the solvent system comprises a polar solvent mixed with tert-amyl alcohol, tert-butyl alcohol, tetrahydrofuran, acetone, methanol, or acetonitrile.
- the polar solvent comprises dimethyl sulfoxide (DMSO), pyridine, or dimethylformamide (DMF).
- the method further comprises heating to a temperature between 40° C. to 100° C.
- the method further comprises vacuum distillation to remove the solvent system and isolating the product of interest.
- the present invention provides a method for producing one or more compounds of formula (I), formula (II), formula (III), formula (IV) or formula (V) by an acid or base catalyzed trans-esterification reaction of an appropriate disaccharide with a suitable vinyl ester in a solvent system.
- the base is potassium carbonate (K 2 CO 3 ), sodium hydroxide (NaOH), or potassium hydroxide (KOH).
- the acid is sulfuric acid (H 2 SO 4 ) or hydrochloric acid (HCl).
- the vinyl ester comprises vinyl acetate, vinyl propionate, vinyl butyrate, vinyl cinnamate, vinyl methacrylate, vinyl oleate, vinyl linoleate, vinyl palmitate, or vinyl stearate.
- the solvent system comprises a polar solvent such as dimethyl sulfoxide (DMSO), pyridine, or dimethylformamide (DMF).
- the present invention provides a method for producing one or more compounds of formula (VI) comprising reacting natural lactonic sophorolipid with formic acid or acetic acid under substantially non-aqueous conditions and partially or completely removing formate or acetate esters formed.
- a second acid catalyzes the reaction of the natural sophorolipid with formic acid or acetic acid.
- the second acid comprises sulfuric acid (H 2 SO 4 ) or hydrochloric acid (HCl).
- the natural sophorolipid is produced by a fermentation host.
- the fermentation host is Candida bombicola .
- the substantially non-aqueous conditions comprise a reaction mixture having a water content of no more than about 10%.
- Another embodiment further comprises the step of heating at a temperature between 40° C. to 120° C. before the step of partially or completely removing the formate or acetate esters formed.
- the removal of the formate esters comprises refluxing in acetic acid and methanol.
- the removal of the acetate esters comprises treating with an acid or a base.
- the present invention provides a method for producing one or more compounds of formula (VII) by a fermentation host.
- the fermentation host is Candida bombicola .
- the compounds of formula (VII) and (VIIa) are isolated from a crude mixture from a culture of Candida bombicola.
- the present invention provides a method for producing sophorose comprising reacting natural sophorosides with formic acid under substantially non-aqueous conditions and completely removing formate esters formed, wherein a purified sophorose is obtained.
- the natural sophorosides are steviosides, sophorolipids, and flavonoid sophorosides.
- the step of reacting natural sophorosides with formic acid step is catalyzed by a second acid.
- the second acid comprises sulfuric acid (H 2 SO 4 ) or hydrochloric acid (HCl).
- the substantially non-aqueous conditions comprise a reaction mixture having a water content of no more than about 10%.
- the method further comprises the step of heating at a temperature between 40° C. to 120° C. before the step of completely removing the formate esters.
- the step of completely removing the formate esters comprises treating with a base in a solvent.
- the base is sodium methoxide (CH 3 NaO) or ammonia (NH 3 ) and the solvent is methanol or ethanol.
- the present invention provides a compound having a structure of formula (II):
- R a is H or C(O)R
- R b is H or C(O)R
- R c is H or C(O)R
- R is an aliphatic moiety, with the proviso that R c is H when R a is H or C(O)CH 3 and R b is H or C(O)CH 3 .
- R is selected from the group consisting of unsubstituted C 1 -C 24 alkyl; C 1 -C 24 alkyl substituted with hydroxyl, carboxyl or aromatic groups; unsubstituted C 2 -C 24 alkenyl; and C 2 -C 24 alkenyl substituted with hydroxyl, carboxyl or aromatic groups.
- R is an aliphatic moiety selected from unsubstituted C 1 -C 24 alkyl, substituted C 1 -C 24 alkyl, unsubstituted C 2 -C 24 alkenyl, and substituted C 2 -C 24 alkenyl.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with hydroxyl groups and C 2 -C 24 alkenyl substituted with hydroxyl groups.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with carboxyl groups and C 2 -C 24 alkenyl substituted with carboxyl groups.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with aromatic groups and C 2 -C 24 alkenyl substituted with aromatic groups.
- FIG. 1 shows examples of carbohydrate esters for use as inducers for gene expression: (A) 6′′ acetylated lactose monoester; (B) 6′ and 6′′ acetylated alpha-sophorose diester; (C) 6′ and 6′′acetylated maltose diester; (D) a deacetylated or 6′ and/or 6′′ acetylated alpha-sophorose ester esterified at C-4′′ position with an 18-carbon monounsaturated fatty alcohol hydroxylated at the C-17 position of the fatty alcohol chain; and (E) a deacetylated or 6′ and/or 6′′ acetylated dimeric sophorolipid ester.
- R d H or C(O)CH 3
- R e H or C(O)CH 3
- R f H or C(O)CH 3
- R g H or C(O)CH 3 .
- FIG. 2 shows examples of two additional compounds resulting from the formic acid treatment of lactonic sophorolipid containing a monounsaturated fatty acyl moiety: (A) sophorose ester with a 17-hydroxy fatty acyl group substituted with an additional hydroxyl at 9 position and (B) at 10 position.
- R d H or C(O)CH 3
- R e H or C(O)CH 3
- R f H or C(O)CH 3
- R g H or C(O)CH 3 .
- FIG. 3 depicts a synthesis route for the preparation of carbohydrate esters: (A) preparation of lactose, cellobiose, maltose, and sophorose esters through chemical or enzymatically catalyzed trans-esterification; and (B) preparation of sophorolipid and dimeric sophorolipid ester through C. bombicola fermentation and preparation of sophorose and sophorose ester through formic acid treatment of sophorolipid followed by full and partial de-esterification, respectively.
- the present invention relates to the chemical or biological modification of known carbohydrate inducers such as lactose, sophorose, and maltose in a cost effective manner that enhances their induction power in the production of industrially desirable proteins.
- carbohydrate inducers such as lactose, sophorose, and maltose
- the induction power of lactose, sophorose, and maltose is enhanced by several folds by modification to disaccharide esters, in particular as soluble monoesters, diesters, and triesters.
- Significantly improved yields of cellulase, amylase or other proteins under the control of a suitable promoter can be induced at higher yields than is currently possible.
- the present invention has the potential to significantly impact current enzyme production economics by improving both productivity and operations logistic in the manufacturing plant.
- the present invention also relates to a more effective method to produce novel and highly inductive sophorose esters from natural lactonic sophorolipid and the use of a novel, sophorolipid dimer ester compound as a highly potent inducer. Due to the ease of preparation of this new class of compounds, ready-to-use and industrially applicable inducers can be produced, which are also highly efficient and cost-effective. Furthermore, a more effective method of producing sophorose from natural sophorosides such as stevioside and sophorolipid is also described.
- Lactose, sophorose, cellobiose, maltose, or isomaltose monoester or diester compounds are produced by a trans-esterification reaction of unmodified disaccharide and a vinyl ester according to the method of the present invention.
- FIG. 1A shows a lactose monoacetate ester
- FIG. 1B depicts a sophorose diacetate ester.
- FIG. 1C shows a maltose diacetate ester. All three compounds are esterified at the 6′ and/or 6 position.
- sophorose esters are produced by the reaction of formic acid or acetic acid with natural lactonic sophorolipids under non-aqueous conditions resulting in a formyl- or acetyl-protected and C-1′ ring-opened sophorolipid. This is followed by partial or complete cleavage of the formate or acetate esters from the treated sophorolipid.
- Other side products such as unmodified sophorolipids and higher esters (esters with DS>3), may also be present.
- 1D depicts a deacetylated or 6′ and/or 6′′ acetylated alpha-sophorose ester esterified at C-4′′ position with an 18-carbon monounsaturated fatty alcohol hydroxylated at the C-17 position of the fatty alcohol chain.
- the compound was produced by formic acid reaction of natural diacetylated lactonic sophorolipid (obtained from the culture of C. bombicola ) catalyzed by sulfuric acid followed by cleavage of formate ester from the treated parent compound by heating or refluxing the substrate in an acetic acid and methanol mixture.
- Sulfuric acid is an inexpensive and readily available catalyst.
- Formic acid can also participate in an addition reaction with lactonic sophorolipids that contain unsaturation on their fatty acyl moiety and may result in the formation of a hydroxyl group on the unsaturated positions upon the cleavage of formate ester.
- Two exemplary products are provided in FIG. 2 that result from the formic acid treatment of lactonic sophorolipid containing an 18-carbon fatty acyl moiety monounsaturated at 9 position.
- FIG. 2A and FIG. 2B depict a sophorolipid ester with a 17-hydroxy fatty acid substituted with an additional hydroxyl at 9-position and 10-position, respectively.
- a sophorose dimer is produced by the yeast C. bombicola using the method of the invention.
- the compound may be isolated from the crude culture of C. bombicola where other side products may consist of natural acetylated lactonic or acidic sophorolipid.
- FIG. 1E depicts a deacetylated or 6′ and/or 6′′ acetylated sophorolipid dimer ester esterified at C-4′′ position with an 18-carbon monounsaturated fatty chain.
- the compound is produced by fermentation of C. bombicola using glucose and canola oil as feedstock.
- lactose, sophorose, cellobiose, maltose, isomaltose esters, sophorose ester obtained from formic acid treatment of natural lactonic sophorolipid
- sophorose ester obtained from formic acid treatment of natural lactonic sophorolipid
- sophorolipid dimer produced by the method of the invention have the structures depicted by formula (I), (II), (III), (IV), (V), (VI), and (VII), respectively:
- R a is H or C(O)R
- R b is H or C(O)R
- R e is H or C(O)R
- R d is H or C(O)CH 3 ;
- R e is H or C(O)CH 3 ;
- R f is H or C(O)CH 3 ;
- R g is H or C(O)CH 3 ;
- R is an aliphatic moiety, with the proviso that in formula (II), R c is H when R a is H or C(O)CH 3 and R b is H or C(O)CH 3 .
- R is an aliphatic moiety selected from unsubstituted C 1 -C 24 alkyl, substituted C 1 -C 24 alkyl, unsubstituted C 2 -C 24 alkenyl, and substituted C 2 -C 24 alkenyl.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with hydroxyl groups and C 2 -C 24 alkenyl substituted with hydroxyl groups.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with carboxyl groups and C 2 -C 24 alkenyl substituted with carboxyl groups.
- R is an aliphatic moiety selected from C 1 -C 24 alkyl substituted with aromatic groups and C 2 -C 24 alkenyl substituted with aromatic groups.
- esters produced by the method of the invention have the structures depicted by compounds of formula (Ia), (IIa), (IIIa), (IVa), (Va), (VIa), or (VIIa):
- R d is H or C(O)CH 3 ;
- R e is H or C(O)CH 3 ;
- R f is H or C(O)CH 3 ;
- R g is H or C(O)CH 3 .
- sophorose ester is a novel compound having a structure of formula (II):
- R a is H or C(O)R
- R b is H or C(O)R
- R c is H or C(O)R
- R is an aliphatic moiety, with the proviso that R c is H when R a is H or C(O)CH 3 and R b is H or C(O)CH 3 .
- an “aliphatic” moiety is a non-aromatic carbon moiety.
- an aliphatic moiety may include a linear, branched or cyclic carbon moiety.
- an aliphatic moiety may include a saturated or unsaturated moiety, including both monovalent and bivalent moieties.
- the aliphatic moiety is an aliphatic alkyl, an aliphatic alkenyl, an aliphatic alkynyl, an aliphatic cycloalkyl, an aliphatic cycloalkenyl, an aliphatic cycloalkynyl, or any bivalent radicals thereof.
- Alkyl includes saturated linear or branched hydrocarbon structures, and combinations of these, which contain only carbon and hydrogen atoms when unsubstituted.
- alkyl groups have one to twenty-four carbon atoms (i.e., C 1 -C 24 alkyl), five to twenty-four carbon atoms (i.e., C 5 -C 24 alkyl), or fifteen to eighteen carbon atoms (i.e., C 15 -C 18 alkyl).
- C 1 -C 24 alkyl saturated linear or branched hydrocarbon structures, and combinations of these, which contain only carbon and hydrogen atoms when unsubstituted.
- alkyl groups have one to twenty-four carbon atoms (i.e., C 1 -C 24 alkyl), five to twenty-four carbon atoms (i.e., C 5 -C 24 alkyl), or fifteen to eighteen carbon atoms (i.e., C 15 -C 18 alkyl).
- alkyl group may be substituted.
- substituted alkyl groups may have a hydroxyl substituent.
- Alkyl groups substituted with hydroxyl may include, for example, —(CH 2 ) 2 OH and —(CH 2 ) 4 OH.
- substituted alkyl groups may have a carboxyl substituent.
- Alkyl groups substituted with carboxyl may include, for example, —(CH 2 ) 2 COOH.
- substituted alkyl groups may have an aromatic substituent. Alkyl groups substituted with aromatic may include, for example, —CH 2 (phenyl).
- Cycloalkyl refers to a cyclic alkyl group, and can have one ring (e.g., cyclohexyl) or multiple rings (e.g., adamantyl).
- Alkylene refers to the same residues as alkyl, but having bivalency. Examples of alkylene include methylene (—CH 2 —), ethylene (—CH 2 CH 2 —), propylene (—CH 2 CH 2 CH 2 —), butylene (—CH 2 CH 2 CH 2 CH 2 —), as well as longer chains including —(CH 2 ) 17 —.
- Alkenyl refers to an unsaturated hydrocarbon group having at least one site of olefinic unsaturation (i.e., having at least one moiety of the formula —C ⁇ C—). When the alkenyl has one site of olefinic unsaturation, the alkenyl is monounsaturated. When the alkenyl has two or more sites of olefinic unsaturation, the alkenyl is polyunsaturated.
- alkenyl groups have two to twenty-four carbon atoms (i.e., C 2 -C 24 alkenyl), five to twenty-four carbon atoms (i.e., C 5 -C 24 alkenyl), or fifteen to eighteen carbon atoms (i.e., C 15 -C 18 alkenyl).
- Alkenyl groups may include, for example, —CH 2 —CH ⁇ CH—CH 3 and —(CH 2 ) 7 —CH ⁇ CH—(CH 2 ) 7 —CH 3 .
- the alkenyl group may be substituted.
- substituted alkenyl groups may have a hydroxyl substituent.
- Alkenyl groups substituted with hydroxyl may include, for example, —(CH 2 ) 2 OH and —(CH 2 ) 4 OH.
- substituted alkenyl groups may have a carboxyl substituent.
- Alkenyl groups substituted with carboxyl may include, for example, —(CH 2 ) 2 COOH.
- substituted alkenyl groups may have an aromatic substituent.
- Alkenyl groups substituted with aromatic may include, for example, —CH 2 (phenyl).
- Cycloalkenyl refers to a cyclic alkenyl group and can have one ring (e.g., cyclohexenyl, —CH 2 —CH 2 -cyclohexenyl), or multiple rings (e.g., norbornenyl).
- Alkenylene refers to the same residues as alkenyl, but having bivalency. Examples of alkenylene include ethylene (—CH ⁇ CH—), propylene (—CH 2 —CH ⁇ CH—), butylene (—CH 2 —CH ⁇ CH—CH 2 —), as well as longer chains including —(CH 2 ) 7 —CH ⁇ CH—(CH 2 ) 7 — and —(CH 2 ) 7 —CH ⁇ CH—(CH 2 ) 6 —CH ⁇ CH—.
- carbohydrate esters of the present invention depicted by structures with formula (I) through (VII) and (Ia) through (VIIa) have the following glycosidic linkages: formula (I), (Ia), lactose (gal(beta 1, 4)glc); formula (II), (IIa), sophorose (glc(beta 1, 2)glc); formula (III), (IIIa), cellobiose (glc(beta 1, 4)glc); formula (IV), (IVa), maltose (glc(alpha 1, 4)glc); formula (V), (Va), isomaltose (glc(alpha 1, 6)glc); formula (VI), (VIa), sophorose (glc(beta 1, 2)glc); and formula (VII), (VIIa), sophorose (glc(beta 1, 2)glc).
- One or more carbohydrate esters produced by the methods described herein, or any compositions thereof, can be used as inducers that cause cells to produce large amounts of enzymes or other substances than they would otherwise produce if the inducer were absent.
- Isolated and purified carbohydrate esters produced by the present methods may be used as inducers or the crude reaction mixture containing the carbohydrate esters may be used as an inducer without further purification.
- one or more of the carbohydrate esters produced by methods of the invention described herein, or any compositions thereof can be used for inducing protein production (e.g., cellulase or amylase production) in fermentation host organisms capable of producing cellulase or amylase in a liquid culture containing an appropriate carbon source.
- protein production e.g., cellulase or amylase production
- one or more carbohydrate esters with a structure of formula (I) through (VII), or any compositions thereof can be used to induce protein production.
- filamentous fungi which have the ability to metabolize cellulose or starch by producing cellulases or amylase that can hydrolyze the beta-(1,4)-linked glycosidic bonds of cellulose or alpha-(1,4)-linked glycosidic bonds of starch to produce glucose.
- Suitable filamentous fungi may include all filamentous forms of the subdivision Eumycotina. (See, Alexopoulos, C. J. (1962), Introductory Mycology , Wiley, New York). These fungi are usually characterized by a vegetative mycelium with a cell wall composed of chitin, cellulose, and other complex polysaccharides.
- Suitable species of filamentous fungi or bacteria or other hosts for use with the carbohydrate ester inducers of the present invention include, for example, hosts selected from the following genera: Trichoderma, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces, Thermomonospora, Bacillus, Cellulomonas, Penicillium, Basidiomycete, Chrysoporium, Pestalotiopsis, Neurospora, Cephalosporium, Achlya, Podospora, Endothia, Mucor, Cochliobolus, Myceliopthora, Talaromyces and Pyricularia .
- hosts selected from the following genera: Trichoderma, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces, Thermomonospora, Bacillus, Cellulomonas, Penicillium, Basidiomycete, Chrysoporium, Pestaloti
- Specific hosts may include, for example, Trichoderma reesei (QM 9414, MCG 77, MCG 80, Rut-C30, CL-847, VTT-D, SVG, and RL-P37) (see Esterbauer et al., Bioresource Tech., 36(1):51-65, (1991)), Aspergillus niger, Aspergillus oryzae, Bacillus subtilis, Penicillium decumbens, Penicillium funiculosum, Penicillium purpurogenum, Chrysosporium lucknowense, Myceliopthora thermophila , and Talaromyces emersonii.
- Trichoderma reesei QM 9414, MCG 77, MCG 80, Rut-C30, CL-847, VTT-D, SVG, and RL-P37
- Aspergillus niger Aspergillus oryzae
- Bacillus subtilis Bacillus subtilis
- one or more of the carbohydrate esters produced by the methods of the present invention, or any compositions thereof are used to induce protein production (e.g., cellulase or amylase production) in a host cell that is a member of the species of Trichoderma, Penicillium, Chrysosporium, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces , Thermomonospora, Myceliopthora, Talaromyces, Bacillus or Cellulomonas.
- protein production e.g., cellulase or amylase production
- a host cell that is a member of the species of Trichoderma, Penicillium, Chrysosporium, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces , Thermomonospora, Myceliopthora, Talaromyces, Bacillus or Cellulomonas.
- one or more carbohydrate esters, or any compositions thereof are used to induce protein production (e.g., cellulase or amylase production) in a host cell that is a member of the species of Trichoderma or Aspergillus .
- one or more carbohydrate esters, or any compositions thereof are used to induce protein production in Trichoderma reesei, Trichoderma viride, Aspergillus niger , or Aspergillus oryzae .
- the term “ Trichoderma ” refers to any fungal genus previously or currently classified as Trichoderma .
- the carbohydrate ester is one or more esters with a structure of formula ((I) through (VII), or preferably, structures of formula (Ia) through (VIIa).
- inducers such as lactose, cellobiose, cellulose, cellulose hydrolysates, starch hydrolysate, and sophorose from glucose reversion are typically used to induce protein expression in Trichoderma reesei , while maltose, maltodextrins, starch, and starch hydrolysates are the inducers of choice for Aspergillus spp. In some case, these inducers may not perform optimally due to an insufficient amount or unintended repression by impurities or metabolites. Supplementing conventional inducers with the inducers disclosed herein may increase protein expression over that achievable with conventional inducers alone. Therefore, the use of the inducers of the invention may be useful either alone or in combination with each other or with conventional inducers.
- induction of Trichoderma with lactose is augmented by the addition of the sophorose esters with structure shown in FIG. 1D and FIGS. 2A and 2B .
- induction of Trichoderma with a glucose reversion mixture containing sophorose is augmented by the addition of the sophorose esters with structure shown in FIG. 1D and FIGS. 2A and 2B .
- induction of Trichoderma with a biomass hydrolysate e.g., cellulose, starch
- induction of Aspergillus protein expression with maltose or maltodextrins is enhanced by supplementation of the inducer mixture with the maltose ester(s) with structures depicted by formula IV and FIG. 1C .
- sophorose esters with structures of formula II, VI, and VII may be used to induce enhanced protein production in solid phase fermentation.
- Production of enzymes and other protein products using solid phase fermentation relies on the growth of microbes (in particular, filamentous fungi) on moist solid substrates without free-flowing liquid.
- microbes in particular, filamentous fungi
- solid phase fermentation in some situations can offer significant advantages in both performance and production cost.
- Suitable solid substrates include readily available and inexpensive carbon sources based on agriculture residues such as wheat bran or corn cobs, or mixtures thereof.
- Suitable filamentous fungi for use in this embodiment have been described above and include Trichoderma reesei and Aspergillus niger.
- the solid substrates are moistened with an appropriate nutrient medium to reach a starting moisture content of 40%, 50%, 60%, or 70% to allow the fungi to grow on the substrate.
- these solid substrates might be activated by pretreatment with steam and chemicals known to those skilled in the art.
- Crude or purified sophorose ester is mixed into the solid substrate and fermentation is initiated by inoculating the mixture with an appropriately prepared culture of a suitable filamentous fungi.
- the resulting product for example, an enzyme such as cellulase is then isolated from the mixture by methods known in the art. Typical isolation involves washing the solid state fermentation media with a liquid.
- the solid substrate might be pressed and/or a detergent might be added to the washing liquid to improve efficiency.
- the enzymes are not isolated and are used as produced together with the solid substrate.
- carbohydrate esters described herein, or any compositions thereof may be used with genetically engineered host cells.
- a DNA construct that includes the nucleic acid encoding the amino acid sequence of the designated protein can be constructed and transferred into, for example, a T. reesei, Aspergillus niger , or Aspergillus oryzae host cell.
- the vector may be any vector known in the art which, when introduced into the host cell, can be integrated into the host cell genome and can be replicated.
- the nucleic acid encoding the protein can be operably linked to a suitable promoter, which shows transcriptional activity in a Trichoderma or Aspergillus host cell.
- Suitable promoters may include, for example, cellobiohydrolase 1 (cbh1), endoglucanase, xylanase, glucoamylase A (glaA), and Taka-amylase (amyA).
- the carbohydrate esters described herein with a structure of formula (I), (II), (III), (VI), (VII), or any compositions thereof may be a powerful inducer of the cbh1 promoter in Trichoderma , which may increase cellulase production by several folds compared to other known cellulase inducers.
- the carbohydrate esters described herein with structure of formula (IV), or (V), or any compositions thereof may be a powerful inducer of the glaA or amyA promoter in Aspergillus , which may increase amylase production by several folds compared to other known amylase inducers.
- the carbohydrate esters described herein, or any compositions thereof may induce production of any protein that may be under the control of a native or engineered promoter, such as cbh1 or glaA.
- the promoter may be derived from genes encoding proteins that may be either homologous or heterologous to the host cell.
- a promoter can be engineered to enhance its function and the applicability of this new inducer should not be constrained by its alteration.
- Homologous or heterologous protein expression under this promoter may be routinely carried out using recombinant molecular biology techniques known in the art, which may rely on successful recombination of genes encoding the protein of interest.
- homologous and heterologous proteins of interest include, for example, enzymes, hormones, growth factors, cytokines, vaccines, antibodies, and polypeptides.
- the carbohydrate esters described herein may induce production of enzymes including, for example, cellulases, amylases, proteases, xylanases, lipases, esterases, phytases, pectinases, catalases, pullulanases, laccases, oxidases, glucose isomerases, lyases, acylases, and transferases.
- Fermentation procedures for production of proteins are generally known to one of skill in the art.
- cells are cultured in a medium containing physiological salts and nutrients.
- a medium containing physiological salts and nutrients.
- Trichoderma and Aspergillus cells may be cultured in the medium as described by England et al. (U.S. Published Patent Application No.
- Culture-conditions e.g., temperature, pH, duration
- cultures may be incubated at approximately 28° C. in appropriate medium in shake cultures or fermenters until desired levels of cellulase expression are achieved. After fungal growth has been established, the cells are exposed to conditions effective to cause or permit the expression of the protein.
- An appropriate carbon source is also provided in the culture medium.
- Examples of appropriate carbon source biomass include, but are not limited to, glucose, sucrose, fructose, glycerol, lactose, cellulose, cellulose hydrolysate, starch, starch hydroylsate, maltose, or maltodextrin.
- carbohydrate esters described herein, or any compositions thereof may be added to the medium at a concentration effective to induce protein production (e.g., cellulase or amylase production).
- the esters may also be added to the medium in an insoluble or soluble form.
- the carbohydrate esters can be reconstituted in water or one or more solvents (e.g., ethanol, or dimethyl sulfoxide) prior to the introduction into the fermentation culture as a media component or as an inducing feed. Solubilizing the inducers allows for their use as a concentrated feed for protein production in an industrial fed-batch fermentation process. Further, it should be understood that the carbohydrate ester inducers may be used in a batch, fed-batch, or a continuous fermentation process.
- carbohydrate esters described herein has been found to surprisingly increase cellulase or amylase production by several folds compared to unmodified starting material such as lactose, sophorose, maltose, or natural sophorolipids.
- the use of one or more of carbohydrate esters, or any compositions thereof can increase cellulase production in a Trichoderma host (e.g., T.
- the carbohydrate esters are one or more esters with a structure of formula (I) through (VII), or preferably, with a structure of formula (Ia) through (VIIa).
- carbohydrate esters produced by methods of the present invention may be used to induce protein expression directly as a crude reaction mixture containing other side products
- the active carbohydrate ester components of the crude mixture can be individually separated or isolated, and optionally further purified.
- one or more esters with a structure of formula (I) through (VII), or preferably, with a structure of formula (Ia) through (VIIa) may be isolated for use in protein production.
- the use of purified lactose monoester or sophorose diester isolated from the crude ester mixture may result in at least a one-fold, at least a two-fold, or at least a three-fold increase in cellulase production in Trichoderma compared to the use of an unpurified crude mixture.
- the unmodified lactose or sophorose is the one from which the lactose and sophorose esters were prepared.
- lactose, sophorose, cellobiose, maltose, and isomaltose esters by enzymatic or chemically catalyzed trans-esterification of unmodified disaccharides with a vinyl ester.
- esterifying carbohydrates including, for example, chemical or enzymatic synthesis of sucrose esters (Polat and Linhardt, J. Surfact. Deterg., 4(4):415-421 (2001)), enzymatic synthesis of a maltose monolaurate ester (Plou et al., J.
- One or more compounds of formula (I) through (V) are prepared by: a) providing a disaccharide such as lactose, sophorose, cellobiose, maltose, or isomaltose, preferably dry and preferably in high purity; and b) contacting the disaccharide with a vinyl ester and an enzyme or chemical catalyst in a suitable solvent system to produce the composition.
- the reaction mixture is heated to a temperature of 40° C. to 100° C.
- the acid hydrolysis may be performed at a temperature of at least 40° C., at least 50° C., at least 60° C., at least 70° C., at least 80° C., at least 90° C., or at least 100° C.
- the method for producing a composition that includes one or more compounds of formula (I) through (V) further includes vacuum distillation to remove the solvent; and isolating the product of interest from the composition.
- Vinyl esters may be fatty acid vinyl esters or aromatic vinyl esters. Suitable fatty acid vinyl esters include vinyl acetate, vinyl propionate, vinyl butyrate, vinyl methacrylate, vinyl oleate, vinyl linoleate, vinyl palmitate, and vinyl stearate. Examples of aromatic vinyl esters include vinyl cinnamate and vinyl caffiate.
- Suitable lipase enzymes for use in the method of the present invention include Novozyme 435 (immobilized Candida antarctica lipase B), Lipozyme® TL, Lipozyme® RM, and Amano lipase PS.
- the enzyme catalyst can be replaced with a chemical catalyst (e.g., potassium carbonate (K 2 CO 3 ), sodium hydroxide (NaOH), sulfuric acid (H 2 SO 4 ), and hydrochloric acid (HCl)) and the vinyl ester can be replaced with acyl chlorides (e.g., acetyl chloride or palmitoyl chloride).
- a chemical catalyst e.g., potassium carbonate (K 2 CO 3 ), sodium hydroxide (NaOH), sulfuric acid (H 2 SO 4 ), and hydrochloric acid (HCl)
- the vinyl ester can be replaced with acyl chlorides (e.g., acetyl chloride or palmitoyl chloride).
- Suitable solvents include dimethyl sulfoxide (DMSO), pyridine, dimethylformamide (DMF), methyl ethyl ketone, isobutanol, tert-amyl alcohol, tert-butyl alcohol, tetrahydrofuran, acetone, or mixtures thereof.
- DMSO dimethyl sulfoxide
- DMF dimethylformamide
- methyl ethyl ketone methyl ethyl ketone
- isobutanol tert-amyl alcohol
- tert-butyl alcohol tetrahydrofuran
- acetone or mixtures thereof.
- the methods described herein involve enzymatically or chemically modifying disaccharides by trans-esterification reaction with a vinyl ester.
- modified disaccharide esters are highly inductive to protein production (e.g., cellulase or amylase production) in filamentous fungi host cells (e.g., Trichoderma or Aspergillus ), exceeding the inductive ability of unmodified starting materials by several folds.
- the methods described herein typically yield a crude mixture consisting of active carbohydrate ester as component(s). Any separation techniques known in the art may be employed to isolate the active esters, for example, vacuum distillation, precipitation, crystallization, solvent extraction, or column chromatography.
- disaccharides and soluble polysaccharides may be modified into potent inducers using the same principles disclosed in this invention.
- examples of other disaccharides include sucrose, trehalose, gentiobiose, laminaribiose, and xylobiose.
- examples of polysaccharides include cellodextrins and maltodextrins.
- a natural lactonic sophorolipid needs to be ring-opened through selective cleavage of the ether-like linkage at the C-1 (the anomeric carbon) position, followed by regeneration of the hydroxyl group of the hydroxy fatty acid, which remains linked by an ester bond to C-4′′ (as shown in FIG. 1D ).
- Previously described methods for this transformation are limited by the low yields obtained.
- the inventor disclosed the use of 0.1N hydrochloric acid with natural sophorolipid under aqueous conditions to produce these compounds (International application no.: WO 2013/003291).
- the present invention comprises a high yield method involving the reaction of formic or acetic acid with natural lactonic sophorolipid carried out under non-aqueous conditions.
- This new method promotes cleavage of the ether-like linkage (C-1′) in preference to the ester linkage (C-4′′) of the natural lactonic sophorolipid, thus resulting in a high yield.
- Unintended formate and acetate esters may be formed with the open hydroxyls during the formic acid or acetic acid treatment of sophorolipid, which require cleavage in order to yield compounds described by formula (VI).
- the formic acid or acetic acid reactions may be catalyzed by another acid.
- suitable acid catalyst include, for example, sulfuric acid (H 2 SO 4 ) or hydrochloric acid (HCl), or mixtures of acid catalysts, at a concentration (wt %) between about 0.05% to about 1%.
- Appropriate concentrations include 0.05%, 0.10%, 0.15%, 0.20%, 0.30%, 0.50%, 0.75%, and 1%.
- the natural lactonic sophorolipid may be produced by a fermentation host, including, but not limited to, C. bombicola .
- Substantially non-aqueous conditions may comprise a water content of no more than about 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or less than 1%, by weight.
- the acid treatment is performed at elevated temperatures.
- the formic acid and acetic acid treatment may be characterized as a formolysis and an acetolysis reaction, respectively.
- the formolysis or acetolysis may be performed at a temperature of at least 40° C.
- the formolysis or acetolysis may be performed at a temperature of at least 80° C., at least 90° C., at least 100° C., at least 110° C. or at least 120° C.
- the formolysis or acetolysis may be performed at a temperature between 40° C. and 120° C., or between 100° C. and 120° C.
- the natural sophorolipid mixture can be contacted with the acid at elevated temperatures for a range of time, e.g., from minutes to hours.
- the cleavage of formate ester from the lactone ring-opened sophorolipid involves heating or refluxing the starting material in an acetic acid and methanol mixture.
- the ratio of acetic acid to methanol may be 3:2 (v/v).
- the cleavage of acetate esters involves treating the starting material with an acid, for example, HCl, or a base, for example, ammonia, or an enzyme, for example, esterase.
- the cleavage of the formate or the acetic ester from the treated sophorolipid may be partial. Migration of fatty and acetyl acyl groups may occur during the cleavage.
- the lactonic sophorolipid containing single or multiple unsaturation on its fatty acid acyl moiety may participate in an addition reaction with formic acid at the unsaturated positions and the cleavage of formate esters may result in the formation of the hydroxyl group on the unsaturated positions in cases where the sophorose ester contains mono or polyunsaturated fatty acid moieties, for example, in compounds of described in FIG. 2 .
- One of skill in the art would recognize that a partial cleavage of formate and acetate ester, acyl migrations, and hydroxylation of unsaturation may result in new compounds that may be equal to or more inductive than the compounds with structures depicted by (VI). The applicability of this method is not be constrained by this variation.
- the natural lactonic sophorolipid may be first pretreated with formic anhydride or acetic anhydride to yield a compound that is protected by formic and/or acetic esters on all open hydroxyls. This is then followed by the formic and acetic acid treatment to selectively cleave the sophorolipid lactone ring at the C-1′ anomeric position and followed by the partial or complete cleavage of formic and acetic ester from the hydroxyls.
- This pretreatment may result in a significant increase in yield with an improved selectivity at the C-1′ anomeric position.
- the natural laconic sophorolipid may be first pretreated with a hydrogenation reaction to remove potential unsaturations on its fatty acyl group (e.g., monounsaturated 17-hydroxy oleic acid, diunsaturated 17-dihydroxy linoleic acid).
- a hydrogenation reaction to remove potential unsaturations on its fatty acyl group (e.g., monounsaturated 17-hydroxy oleic acid, diunsaturated 17-dihydroxy linoleic acid).
- fatty acyl group e.g., monounsaturated 17-hydroxy oleic acid, diunsaturated 17-dihydroxy linoleic acid.
- sophorolipid dimer described by formula (VII) as a highly potent inducer.
- This compound was recently described by Price et al. ( Carbohyd. Res., 348:33-41 (2012), although Price et al. did not recognize its potential in gene induction.
- sophorolipid dimer e.g. acetylated and deacylated lactonic or acidic sophorolipids
- Suitable fermentation hosts for the sophorolipid dimer include, for example, C. bombicola .
- Examples of an appropriate feedstock for this fermentation method comprises glucose and a vegetable oil, including, but not limited to, canola, soybean, corn, or palm oil.
- compounds of formula (VII) may be isolated as a crude mixture from the culture of Candida bombicola , and still possess surprisingly strong inductive effects.
- sophorose by reacting formic acid with natural sophorosides under non-aqueous conditions, followed by complete cleavage of unwanted formate esters.
- Several low yield methods are currently known in the art that include direct synthesis (Coxon and Fletcher, J. Org. Chem., 26(8):2892-2894 (1961)), acetic acid and hydrobromic acid reaction with stevioside octacacetate followed by deacetylation (Vis and Fletcher, J. Am. Chem. Soc., 78:4709-4710 (1956)), and a dilute hydrochloric acid treatment of stevioside followed by purification (Kusakabe et al., Agric. Biol. Chem., 51(8):2255-2256 (1987)).
- a sophoroside is any compound that consists of sophorose as one of its component.
- sophorosides include stevioside, sophorolipids and flavonoid sophorosides.
- the formic acid reactions may be catalyzed by another acid.
- suitable acid catalyst include sulfuric acid (H 2 SO 4 ) and hydrochloric acid (HCl), or mixtures of acid catalysts, at a concentration (wt %) between about 0.05% to about 1%.
- Appropriate concentrations include 0.05%, 0.10%, 0.15%, 0.20%, 0.30%, 0.50%, 0.75%, and 1%.
- the sophoroside is a sophorolipid is produced from a fermentation host, including, but not limited to, C. bombicola .
- the substantially non-aqueous conditions may comprise a water content of no more than about 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or less than 1%, by weight.
- the formic acid treatment is performed at elevated temperatures.
- the formic acid formolysis may be performed at a temperature of at least 40° C.
- the formolysis may be performed at a temperature of at least 80° C., at least 90° C., at least 100° C., at least 110° C. or at least 120° C.
- the formolysis may be performed at a temperature between 40° C. and 120° C., or between 100° C. and 120° C.
- the natural sophorolipid mixture can be contacted with the formic acid at elevated temperatures for a range of time, e.g., from minutes to hours.
- the cleavage of formate esters from the treated sophoroside involves treating the reaction mixture with a base in a solvent.
- suitable base include, but are not limited to, sodium methoxide (CH 3 NaO) and ammonia (NH 3 ).
- suitable solvents include, but are not limited to, methanol, ethanol, and 1-propanol.
- the sophorosides may be first pretreated with formic anhydride or acetic anhydride to yield a compound that is protected by formic and/or acetic esters on all open hydroxyls. This pretreatment is then followed by the formic acid treatment to selectively cleave the sophorosides at the C-1′ anomeric position, followed by complete cleavage of formic and acetic ester from the hydroxyls.
- This pretreatment may result in a significant increase in yield of sophorose due to an improved selectivity at the C-1′ anomeric position.
- the formic acid treatment of a sophoroside based on natural lactonic and/or acidic sophorolipid may be carried out first after a hydrogenation reaction to remove potential unsaturations on its fatty acyl group.
- a hydrogenation reaction to remove potential unsaturations on its fatty acyl group.
- Sophorose may be isolated and purified from the final reaction mixture through methods known in the art. Suitable purification methods include, for example, chromatography, adsorption, extraction, precipitation, re-precipitation, crystallization, and recrystallization.
- the afore-mentioned natural lactonic sophorolipid mixture and sophorolipid dimers may be prepared from microbial cultures using yeast.
- suitable yeast strains may be selected from, for example, the following genera: Candida, Starmerella, Rhodotorula , and Wickerhamiella .
- Specific strains suitable for sophorolipid production include, for example, C. bombicola (e.g., ATCC 22214, NRRL Y-30816), Starmerella bombicola, Candida apicola, Candida riodocensis, Candida stellata , and Candida sp. NRRL Y-27208. (See Kurtzman et al., FEMS Microbiol. Lett., 311:140-146 (2010)).
- the natural sophorolipid mixture is produced by the yeast C. bombicola or Candida apicola .
- C. bombicola has an active extracellular lipase system that first cleaves triglycerides from vegetable oil into free fatty acids, which are readily taken up by the yeast. The fatty acids then undergo hydroxylation at the ultimate or penultimate carbon through the action of cytochrome P450. Sophorose is then added onto the hydroxylated fatty acid by the actions of two glycosyltransferases. (See Fleurackers, Eur. J. Lipid Sci. Technol., 108: 5-12, (2006)). Acetylation and lactonization complete the formation of sophorolipids, which are then secreted by the yeast.
- Suitable carbon substrates used in the fermentation to produce the natural sophorolipids may include hydrophobic substrates, for example, vegetable oils (e.g., canola, soy, corn, palm, coconut, sunflower seed, cottonseed, or olive oils), fatty acids (e.g., palmitic, oleic, elaidic, linoleic, alpha-inolenic, or stearic acids), fatty acid esters (e.g., fatty acid methyl ester or fatty acid ethyl ester), alkanes (e.g., pentadecane, hexadecane, heptadecane, or octadecane), and fatty alcohols (e.g., pentadecanol, hexadecanol, heptadecanol, or octadecanol).
- vegetable oils e.g., canola, soy, corn, palm, coconut, sunflower seed,
- the length of the carbon substrates used in the fermentation to produce the natural sophorolipids generally depend on the fermentation host.
- a Candida host e.g., C. bombicola
- the fatty acids and/or alkanes have a chain length of between fifteen and eighteen carbon atoms.
- fatty acids with carbon chains of between fifteen and eighteen carbon atoms may be preferable to alkanes with carbon chains of between fifteen and eighteen carbon atoms.
- the carbon substrate used in the fermentation to produce the natural sophorolipids is canola oil, which has a high C$ content and a monounsaturated fatty acid chain.
- canola oil which has a high C$ content and a monounsaturated fatty acid chain.
- other longer or shorter carbon substrates can be used, but can be reduced or elongated to between 15 and 18 carbon-member chains for use with a Candida host.
- Yeast typically produces a mixture of sophorolipids, and the sophorolipid molecules of the mixture usually have one sophorose molecule linked to a hydroxylated fatty acid at the C-1′ position of the sophorose molecule.
- the natural sophorolipid mixture may include diacetylated sophorolipids in either lactonic or acidic forms.
- diacetylated lactonic sophorolipids are typically present in a greater amount (e.g., greater than 60%) than acidic sophorolipids (e.g., less than 10%). See Asmer et al., J. Am. Oil Chem.
- sophorolipids of the natural sophorolipid mixture typically have acetyl groups at the C-6′′ and/or C-6′ positions of the sophorose molecule. See Van Bogaert et al., Process Biochemistry 46(4):821-833 (2011).
- the fatty acid groups may be saturated or unsaturated, and may vary in length.
- sophorolipids in a natural sophorolipid mixture have a fatty acid chain of sixteen to eighteen carbon atoms.
- the composition of the natural sophorolipid mixture may depend on the type of feedstock and culture conditions. For example, if the feedstock is a fatty acid ester rather than vegetable oil or free fatty acids, more of the free acidic sophorolipids may be produced. (See Ashby et al., U.S. Published Patent Application No. 2006/0199244.) On the other hand, if an alkane such as hexadecane or heptadecane is used, more of the actonic sophorolipids are produced. (See Glenns and Cooper, J. Am. Oil Chemist Soc., 83(2):137-145 (2006).)
- This example describes the preparation of the lactose acetate esters depicted in FIG. 1A from lactose using enzyme-catalyzed trans-esterification, which enhances their protein induction power in Trichoderma.
- the preparation starts first with dissolving 25 mg of D-lactose (Sigma-Aldrich) with 0.20 mL of dimethyl sulfoxide (DMSO) in a 20 mL glass scintillation vial. This was followed with the addition of 1.8 mL of tert-amyl alcohol, 0.125 g of molecular sieve (SYLOSIV, WR Grace, Columbia, Md.), and 0.125 g of immobilized lipase enzyme (Lipozyme TL, Novozymes, Franklinton, N.C.). The mixture was pre-incubated inside a shaker incubator at 50° C.
- the crude product mixture was removed from the scintillation vial and recovered as the supernatant via centrifugation where the solvents were evaporated using a SpeedVac concentrator (Savant, Thermo Scientific).
- a SpeedVac concentrator Savant, Thermo Scientific
- the lactose monoacetate was fractionated from the crude mixture by flash chromatography.
- a 5 g self-packed silica gel (Fisher, 230-400Mesh) column was used with an eluent (1-propanol:ethyl acetate:water, 4:5:1) with isocratic elution.
- the purity of the lactose monoacetate ester was confirmed via LC-MS using a Waters 2695 HPLC with Waters ZQ 2000 Mass spectrometer and a Waters 2487 UV detector.
- the analysis was conducted using a Waters Symmetry C 18 column (4.6 ⁇ 250 mm, 5 ⁇ m) with a (5%/95%) acetonitrile and water eluent containing 0.1% formic acid as the mobile phase run isocratically for a total run time of 15 minutes.
- the media composition as modified from England et al. (U.S. Pat. No. 7,713,725), consists of 14.4 g/L citric acid, 4 g/L KH 2 PO 4 , 6.35 g/L (NH 4 ) 2 SO 4 , 2 g/L MgSO 4 -7H 2 O, 0.53 g/L CaCl 2 -2H 2 O, and trace metal elements at 1 mL/L comprising 5 g/L FeSO 4 -7H 2 O, 1.6 g/L MnSO 4 —H 2 O, and 1.4 g/L ZnSO 4 -7H 2 O.
- T. reesei Rut-C30 a cellulase hyper-secretor, was selected as the host to test for protein expression. It was obtained from ATCC (56765) and developed as a catabolic de-repressed strain from classic mutagenesis of parent strain NG14 and the wild type QM6A (Seidl et al., BMC Genomics, 9:327, (2008)).
- To propagate Trichoderma the freeze-dried stock from ATCC was first dissolved in sterile deionized water and then transferred onto a PDA (potato dextrose agar) plate (Teknova P0047) using a sterile loop. The PDA plate was maintained at room temperature under white fluorescent light and after approximately 7 days, green Trichoderma spores could be seen.
- 60% (w/v) glucose stock was prepared and used both as control and as the carbon source for Trichoderma growth.
- glucose stock was first placed into 14 mL of citrate minimal media inside a 125 mL baffled flask, followed by the addition of 0.5 mL of prospective inducer.
- glucose (no inducer) control 0.5 mL of glucose stock was placed into 14.5 mL minimal media to give a final glucose concentration of 2%.
- an approximately 1 cm by 1 cm square agar plug was removed from the Trichoderma spore-containing PDA agar plate using a sterile loop and placed into the protein induction culture media to be tested. The cultures were placed inside a 28° C. incubator with shaking at 175 RPM.
- CMC carboxymethylcellulose
- T. reesei Rut-C30 is a cellulase hyper-producer
- the CMC activity directly correlates with the amount of protein being induced.
- the CMC activity assay follows a procedure modified from Mandels and Reese with a 0.3 mL reaction volume ( J. Bacteriol., 73:269-278, (1957)).
- One CMC unit denotes the activity that liberates 1 ⁇ mol of reducing sugars (expressed as glucose equivalents) in one minute under specified conditions of 50° C. and pH 4.8.
- the purified lactose monoacetate was confirmed by LC-MS to contain a molar mass of 384 (402 [M+NH 4 ] + and 407 [M+Na] + ).
- the structure of the lactose monoacetate was further confirmed by analysis using nuclear magnetic resonance (NMR; Varian 400 mHz).
- the lactose monoacetate as depicted in FIG. 1A was confirmed to be an ⁇ and ⁇ anomer mixture of lactose monoacetylated at 6′′ position.
- the assignments of protons and carbons for the isolated lactose monoacetate fraction are summarized in Table 2 below.
- sophorose acetate esters can be prepared from sophorose through enzyme-catalyzed trans-esterification, which enhances its protein induction power in Trichoderma .
- the CMC activity results shown in Table 3 compare the protein induction power of the crude sophorose acetate ester mixture and purified sophorose diacetate ester to that of sophorose.
- the crude mixture even though impure is already highly efficient and powerful and at 0.17 g/L. Its specific induction power at 70.2 U/mg is ⁇ 3 times that of unmodified sophorose.
- the purified sophorose diacetate ester is even more powerful and at 0.12 g/L. Its specific induction power at 193.3 U/mg is ⁇ 7_times that of unmodified sophorose.
- the crude sophorose acetate mixture was analyzed by LC-MS using the same procedure described in Example 1 and was found to consist of a mixture of sophorose monoacetate with a mass of 384 (402 [M+NH 4 ] + ), diacetate with a mass of 426 (444 [M+NH 4 ] + ), and unreacted sophorose. From the LC-MS, the purity of purified sophorose diacetate ester was confirmed.
- sophorose palmitate belonging to the structure class with formula (II) can be prepared from sophorose through enzyme-catalyzed trans-esterification to further enhance its protein induction power in Trichoderma.
- the CMC activity results shown in Table 4 compare the protein induction power of the crude sophorose palmitate mixture to that of sophorose.
- the crude mixture even though impure, is already highly efficient and powerful at 0.17 g/L. Its specific induction power at 73.8 U/mg is similar to the crude sophorose acetate mixture (Table 3) and is ⁇ 3 times that of unmodified sophorose.
- the crude sophorose monopalmitate mixture was analyzed by LC-MS using the same procedure described in Example 1 except a mobile phase of (70%/30%) acetonitrile and water containing 0.1% formic acid was used and the purification was run isocratically for a total run time of 30 minutes.
- the sample was found to consist of a mixture of monopalmitates with a molar mass of 580 (603 [M+Na]+) and dipalmitates with a mass of 818 (841 [M+Na]+).
- lactose acetate ester can be also prepared from lactose through chemically-catalyzed trans-esterification to enhance its protein induction power in Trichoderma.
- the procedure starts first with preparing a 0.4 M lactose solution in dimethyl sulfoxide (DMSO).
- DMSO dimethyl sulfoxide
- the solution (2 mL) was mixed with 3 mg of potassium carbonate (K 2 CO 3 ) catalyst and preheated at 50° C. for 30 minutes to activate the catalyst.
- K 2 CO 3 potassium carbonate
- the reaction was initiated by adding vinyl acetate with differing molar ratios (vinyl acetate: lactose) in order to control the degree of substitution.
- Each reaction had a volume of 200 ⁇ L and was heated to 60° C. for 30 minutes using a thermocycler without stirring.
- the subsequent sample recovery and induction study followed the procedure described in Example 1.
- the crude lactose acetate mixture prepared chemically with a varying vinyl acetate to lactose ratio, consists of a mixture of acetates with multiple degree of substitution.
- high vinyl acetate to lactose ratio e.g. 4:1
- majority are triacetates and diacetates while at lower ratio (e.g. 1:4)
- majority are monoacetates and unmodified lactose.
- a ratio of 2:1 gave the highest induction, yielding a product consisting of mainly mono, di, and triacetate esters.
- sophorose acetate esters can be also prepared from sophorose through chemically-catalyzed trans-esterification and how they can be further purified to enhance their protein induction power in Trichoderma .
- the procedure of preparing sophorose acetate esters chemically follows the same procedure described in Example 4 and subsequent sample recovery and induction study followed the procedure detailed in Example 1 except the crude mixture was further purified based on procedure described in Example 1 to isolate the sophorose diacetate ester.
- the crude sophorose acetate mixture prepared chemically with a varying vinyl acetate to sophorose ratio, consists of a mixture of acetates with multiple degree of substitution.
- the products are mainly tri-, tetra-, penta-, and hexa-acetates, while at lower ratio (e.g. 1:4), the products are mainly are di- and mono-acetates and unmodified sophorose.
- the ratio of 1:1 gave the highest induction, and the majority of the products are mono-, di-, and tri-acetate esters.
- the purified sophorose diacetate ester was confirmed by LC-MS to contain a molar mass of 426 (444 [M+NH4]+ and 449 [M+Na]+).
- the structure of the sophorose diacetate was further confirmed by analysis using nuclear magnetic resonance (NMR; Varian 400 mHz).
- sophorose diacetate as depicted by FIG. 1B was confirmed to be an alpha-sophorose diester acetylated at both 6′ and 6′′ position.
- the assignments of protons and carbons for the isolated sophorose acetate fraction are summarized in Table 7 below.
- maltose acetate ester can be also prepared from maltose through chemically-catalyzed trans-esterification to enhance its protein induction power in Aspergillus .
- the procedure of preparing maltose acetate chemically and subsequent sample recovery follows the same procedure described in Example 4.
- a minimum media was first prepared with 1 g/L KH 2 PO 4 , 2 g/L NH 4 Cl, 0.5 g/L MgSO 4 -7H 2 O, 0.2 mg/L CuSO 4 -5H 2 O, 12.5 mg/L FeSO 4 -7H 2 O, 1 mg/L ZnSO 4 -7H 2 O, and 0.09 mg/L MnSO 4 .
- Aspergillus niger obtained from ARS culture collection, was maintained on a PDA plate and allowed to sporulate for a week at room temperature. For inoculation, a 2 cm by 2 cm area agar plug was first removed and suspended in 5 mL sterile water. The spores were washed off from agar with vigorous agitation and 1 mL of the suspension was used as inoculum with 14 mL media and 1% sorbitol as carbon source in a 125 mL baffled flask. The cultures were allowed to progress inside a shaker incubator (28° C. and 200 RPM) for 2 days at which time the inducer was added. After additional 24 hours, the cultures were assayed for amylase activity following similar procedures to those detailed by Barton et al. ( J. Bacteriol., 1972, 111(3):771-777).
- the crude maltose acetate mixture prepared chemically with a varying vinyl acetate to maltose ratio, consists of a mixture of acetates with multiple degree of substitutions.
- the product is mainly tri-, tetra-, penta-, and hexa-acetates, while at a lower ratio (e.g. 1:2), the product is mainly tri-, di-, and mono-acetates and unmodified maltose.
- the ratio of 2:1 gave the highest induction, and the product is mainly mono-, di-, and tri-acetate esters.
- This example describes a highly effective method of using formic acid to convert non-inductive natural lactonic sophorolipid into novel and highly inductive sophorose esters with structures described by FIG. 1D and FIG. 2 .
- C. bombicola ATCC 22214
- a sample of freeze-dried stock in a glass vial was obtained from ATCC and was first transferred into a yeast extract, peptone, dextrose (YPD) culture broth, then allowed to grow for 48 hours at 28° C. for two days.
- the culture was then mixed with sterilized glycerol to prepare a final culture containing 20% glycerol.
- a cell bank was then established using cryovials with 1 mL of seed culture each, and stored at ⁇ 80° C.
- a production medium was first prepared and included the following components: 100 g/L glucose, 10 g/L yeast extract, 1 g/L urea, and 100 g/L canola oil (Crisco, The J.M. Smucker Company, Orrville, Ohio). Based on the data provided from the manufacturer, the canola oil has 64% monounsaturated fat from mainly oleic fatty acid, and 29% polyunsaturated fat from mainly linoleic and alpha-linolenic fatty acids. To initiate the fermentation, a 1 mL seed of C.
- sophorolipids consisting of mostly diacetylated lactonic sophorolipid
- sophorolipids were allowed to stand until sediment formed, which was recovered by decanting and washing with water followed by freeze drying.
- the purity of harvested samples was confirmed by the result from LC-MS and found be a diacetylated lactonic sophorolipid derivatized with hydroxy oleate fatty groups with a molar mass of 688 (706 [M+H 2 NH 4 ]+ and 711 [M+Na]+).
- the next step was treatment with formic acid.
- the process began by dissolving 5 mg diacetylated lactonic sophorolipid in 200 ⁇ L formic acid. In certain runs, this step was followed by addition of 0.31 ⁇ L (0.15%) of concentrated sulfuric acid.
- the reaction mixture was heated to 80° C. in a thermocycler for 30 minutes without stirring. Water (1 mL) was then added to precipitate the sample, followed by centrifugation to recover the precipitate and drying in a SpeedVac to remove residual water and formic acid.
- the dried sample was then solubilized in 200 ⁇ L acetic acid to methanol (3:2 v/v) solution and heated to 90° C. for 6 hours to cleave unwanted formate ester from the treated sophorolipid. This step was followed with another drying step using a SpeedVac to remove acetic acid and methanol.
- the final samples which were a crude mixture of products, were tested for induction in Trichoderma following the procedure described in Example 1.
- the CMC activity results shown in Table 9 compare the protein induction power of the crude sophorose ester obtained from the formic acid treatment of natural lactonic sophorolipid to other known inducers.
- the tested samples even though impure, were highly efficient and powerful compared to known inducers.
- the natural diacetylated lactonic sophorolipid is not inductive relative to the glucose control and, after formic acid treatment, its specific induction at 0.33 g/Lis enhanced 52-fold. If 0.15% sulfuric acid is used together with formic acid, the specific induction is enhanced by as much as 487-fold at a concentration of 0.03 g/L.
- the specific induction power of the mixture at 496.5 U/mg is 18 times that of sophorose, the current best in class inducer.
- This example illustrates that the natural sophorolipid dimer depicted in FIG. 1E , can also serve as a highly efficient inducer for gene expression in Trichoderma .
- a crude sample containing the sophorolipid dimer was prepared from the cultures of C. bombicola according the procedures described in Example 7 and was typically harvested as a brown oily residue.
- soybean and corn oil were also used as feedstock (Crisco, The J.M. Smucker Company, Orrville, Ohio). In most cases, the C. bombicola yeast did not produce the dimeric sophorolipid.
- LC-MS LC-MS
- the molar masses 1030 and 1028 denote a diacetylated sophorolipid dimer derivatized with an oleate or a linoleate fatty group, respectively.
- the molar masses 1072 and 1070 denote a triacetylated dimer derivatized with an oleate or a linoleate fatty group, respectively.
- the molar masses of 1114 and 1112 denote a tetra-acetylated dimer derivatized with an oleate or a linoleate fatty group, respectively.
- the CMC activity results shown in Table 10 compare the protein induction power of the crude sophorolipid dimer mixture obtained from C. bombicola culture to other known inducers.
- the crude samples even though impure as shown by LC-MS and TLC, are highly efficient and powerful comparing to known inducers.
- the crude sample that does not contain dimers is significantly less inductive than samples containing dimers.
- the specific induction (19.7 U/mg) of the sample containing dimer grown on canola oil is 7 times the induction produced by the sample without dimer and nearly approaches that of sophorose (26.9 U/mg). Since these dimers exist as only trace amounts in the crude sample, purified dimeric compounds once isolated may be even more powerful.
- sophorose needs to become cheaper and more readily available.
- This example provides a simple and effective method to produce sophorose in high yield from formic acid treatment of natural sophoroside (stevioside and sophorolipid) under non-aqueous conditions.
- the procedure is similar to that described in Example 7, except that the samples were freeze dried after formic acid treatment and then solubilized in 0.5 M sodium methoxide in methanol for 15 minutes at room temperature. This process removes unwanted formate or fatty esters to produce sophorose.
- After another drying step using a SpeedVac to remove methanol the sample was analyzed by HPLC (Waters 2695, 401 RI detector, and BioRad HPX-87H column) to determine the sophorose concentration.
- HPLC Waters 2695, 401 RI detector, and BioRad HPX-87H column
- the solid substrate used was a 1:1 blend of wheat bran and corn cob purchased from local pet supply store. Each run consisted of 8 grams of this blend placed into a 125 mL flask, which was then sterilized by autoclaving. The citrate minimum media (pH 4.8) described in Example 1 was then added. The amounts of citrate media added were 5.3 mL, 8 mL, 12 mL, 18.7 mL, which gave a starting moisture content of 40%, 50%, 60%, and 70%, respectively.
- the sophorose ester used was a crude mixture obtained from the formic acid treatment of the natural lactonic sophorolipid (Example 7). For each run, crude sophorose ester (10 mg) premixed with citrate minimum media was then mixed into the solid substrate.
- Fermentation was initiated by mixing a 2 mL inoculum of T. reesei preculture (from day 2, Example 1) into the solid substrate followed by incubating the flasks at 28° C. without shaking. The solid sample from each flask was harvested at day 3 and washed with ten volumes of 50 mM citrate buffer (pH 4.8) and analyzed for CMC activity as described in Example 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
- This application claims the benefit of U.S. Provisional Application Ser. No. 61/673,997, filed Jul. 20, 2012, and 61/746,120, filed Dec. 27, 2012, the contents of which are incorporated in their entirety.
- The U.S. government owns certain rights in the present application pursuant to grant number #2012-33610-19542 from the United States Department of Agriculture.
- The present invention relates to chemical compounds and methods of their preparation for use as inducers of gene expression in cell culturing. More particularly, this invention is related to the development of low cost and highly efficient protein inducers that significantly lower the manufacturing cost for enzyme manufacturers.
- Cheap and readily available industrial enzymes are the key drivers behind the industrial biotechnology revolution where chemicals and energy fuels are increasingly being produced biologically using renewable resources. In contrast to high margin enzymes or other proteins used for therapeutic and diagnostic purposes, industrial enzymes typically have lower margins and are manufactured in large quantities with limited downstream processing after fermentation. For the industrial enzyme market, the production costs are of critical importance to commercial success. In order to fulfill the increasing demand for cheaper and readily available enzymes for the renewable chemicals and energy industries, there is an urgent need for more efficient and cost-effective production processes.
- Major industrial enzyme manufacturers all have significant production capacities devoted to fungal fermentation, in particular using filamentous fungi such as Aspergillus spp, Penicillium spp, Trichoderma spp., Chrysosporium lucknowense (C1) and Myceliophthora thermophila (reclassified)), to make a range of enzyme products used in the textile, detergent, food and feed, and the nascent biofuels industries (Sharma et al., World J. of Microbiol. and Biotech., 25(12):2083-2094 (2009); Visser et al., Industrial Biotech., 7(3):214-223 (2011)).
- Commercial production of a protein of interest in Aspergillus and Trichoderma typically requires an inducer compound that activates the transcriptional switch under a strong native promoter driving a gene of interest expressing a targeted enzyme or protein. Insoluble substrates such as starch and cellulose are typically used in laboratory scale to induce protein expression in Aspergillus and Trichoderma, respectively. Their implementation at industrial scale, however, is hampered by poor substrate consistency and materials and handling issues encountered at large scale such as sterilization, feeding, mixing, and viscosity issues. Consequently, highly efficient soluble inducers are more preferred in the commercial production of enzymes and other proteins.
- Maltose, isomaltose, and maltodextrins are commonly used as soluble inducers for the induction of alpha-amylase and glucoamylase enzymes in Aspergillus spp. (Barton et al., J. Bacteriol., b(3):771-777 (1972)), while sophorose, cellobiose, and lactose are three effective soluble inducers widely used in the industry for enzyme production in Trichoderma spp. (Kubicek et al., Biotech. Biofuels, 2:19 (2009)). Sophorose, a beta 1, 2-disaccharide, is considered to be the most powerful inducer of the cellulase gene promoter in Trichoderma reesei, being 2500 times as active as cellobiose (Mandels et al., J. Bacteriol., 83(2):400-408 (1962)). These respective soluble inducers are all metabolized by Aspergillus or Trichoderma before, during, or after induction. Therefore, they are not considered as gratuitous inducers, thus requiring them to be continually supplied during the fermentation in order to achieve optimum induction.
- In industrial enzyme production through submerged fermentation, soluble inducers are typically supplied to the fermenter in a fed batch either alone or supplemented with alternative carbon sources such as glucose in a carbon-limited fashion. Due to the inducers being non-gratuitous, the induction process, if not fully optimized, will typically cause catabolic repression that significantly lowers the productivity, along with unnecessary growth that significantly lowers the yield. Thus, there exists a need in the art for a stronger, gratuitous, or nearly gratuitous inducer that decouples induction from unintended repression, growth, or other physiological functions, allowing more rigorous process optimization to significantly improve productivity and yield than is currently possible. A more powerful inducer can also be easily used to supply the induction needs of cheaper and non-inductive feedstocks as well as to enhance the induction of conventional inducers such as lactose, cellulose, maltodextrins, or cheaper alternatives such as starch and cellulose hydrolysates, and also in alternative production processes such as solid-phase fermentations.
- Because carbohydrate-based inducers are both inducers and repressors for protein expression, methods to enhance the induction power by modifying the inducer to slow its uptake or metabolization are known. Hydrolysis products of cellobiose octaacetate, although not characterized, are known to carry superior induction power than cellobiose (Mandels and Reese, J. Bacteriol., 79(6):816-826 (1960)). Sucrose monopalmitate induced a sucrase yield that is 80 times that of sucrose in Pullularia pullulans (Reese et al., J. Bacteriol., 100(3):1151-1154 (1969)). Similarly, acetyl cellobioses were more effective than glucose or cellobiose at inducing cellulase in Penicillium purpurogenum, with mono-O-acetyl cellobiose being the most active inducer tested (Suto et al., J. Ferment. Bioengin., 72(5):352-357 (1991)). A recent filing by the inventor (International Application No.: WO 2013/003291) disclosed a novel class of sophorose esters derived from dilute acid treatment of natural sophorolipid that is at least a 30 times more powerful inducer than sophorose itself.
- In one aspect, the present invention provides a method for producing a protein of interest comprising providing a fermentation host and culturing the fermentation host with a carbon source and one or more compounds selected from the group consisting of:
- where Ra is H or C(O)R;
- Rb is H or C(O)R;
- Rc is H or C(O)R;
- Rd is H or C(O)CH3;
- Re is H or C(O)CH3;
- Rf is H or C(O)CH3;
- Rg is H or C(O)CH3; and
- R is an aliphatic moiety, with the proviso that in formula (II), Rc is H when Ra is H or C(O)CH3 and Rb is H or C(O)CH3, wherein the fermentation host is cultured under conditions sufficient to produce a protein of interest. In one embodiment, the protein of interest is cellulase or amylase. In another embodiment, the protein of interest is a homologous or heterologous protein. In a further embodiment, the homologous or heterologous protein is an enzyme, a hormone, a growth factor, a cytokine or an antibody. In one embodiment, the fermentation host is capable of producing cellulase or amylase. In another embodiment, the fermentation host is a filamentous fungus or bacteria or other hosts selected from the genus group consisting of Trichoderma, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces, Thermomonospora, Bacillus, Cellulomonas, Penicillium, Basidiomycete, Chrysoporium, Pestalotiopsis, Neurospora, Cephalosporium, Achlya, Podospora, Endothia, Mucor, Cochliobolus, Myceliopthora, Talaromyces, and Pyricularia. In a further embodiment, the fermentation host is the filamentous fungus Trichoderma reesei or Aspergillus niger. In one embodiment, the fermentation host is grown in a liquid culture or on a solid substrate without free-flowing liquid. In another embodiment, the fermentation host has a promoter operably linked to a gene encoding a protein of interest. In a further embodiment, the promoter is a cellulase gene promoter or an amylase gene promoter. In another embodiment, the promoter is a cbh1 promoter or a glaA promoter or an amyA promoter. In one embodiment, the carbon source is biomass. In another embodiment, the biomass is glucose, sucrose, fructose, glycerol, lactose, cellulose, cellulose hydrolysate, starch, starch hydrolysate, maltose, or maltodextrin.
- In another aspect, the compound of formula (I), (II), (III), (IV) and (V) is isolated from a crude product mixture from either a chemical or enzymatically catalyzed trans-esterification reaction. In one embodiment, the compounds of formula (VI) are isolated from formic acid treatment process of natural lactonic sophorolipid. In another embodiment, the compounds of formula (VII) are isolated from the culture of the yeast Candida bombicola. In another embodiment, R is an aliphatic moiety selected from unsubstituted C1-C24 alkyl, substituted C1-C24 alkyl, unsubstituted C2-C24 alkenyl, and substituted C2-C24 alkenyl. In a further embodiment, R is an aliphatic moiety selected from C1-C24 alkyl substituted with hydroxyl groups and C2-C24 alkenyl substituted with hydroxyl groups. In yet another embodiment, R is an aliphatic moiety selected from C1-C24 alkyl substituted with carboxyl groups and C2-C24 alkenyl substituted with carboxyl groups. In a further embodiment, R is an aliphatic moiety selected from C1-C24 alkyl substituted with aromatic groups and C2-C24 alkenyl substituted with aromatic groups. In another embodiment, the compound of formula (I), (II), (III), (IV), (V), (VI), and (VII) comprises:
- where Rd is H or C(O)CH3;
- Re is H or C(O)CH3;
- Rf is H or C(O)CH3;
- and Rg is H or C(O)CH3.
- In another aspect, the present invention provides a method for producing one or more compounds of formula (I), formula (II), formula (III), formula (IV) or formula (V) comprising providing a disaccharide; and contacting the disaccharide with a vinyl ester in the presence of a lipase enzyme in a solvent system. In one embodiment, the disaccharide comprises lactose, sophorose, cellobiose, maltose, or isomaltose. In another embodiment, the lipase enzyme comprises Novozyme 435, Lipozyme TL, Lipozyme RM, or Amano lipase PS. In a further embodiment, the vinyl ester comprises vinyl acetate, vinyl propionate, vinyl butyrate, vinyl cinnamate, vinyl methacrylate, vinyl oleate, vinyl linoleate, vinyl palmitate, or vinyl stearate. In another embodiment, the solvent system comprises a polar solvent mixed with tert-amyl alcohol, tert-butyl alcohol, tetrahydrofuran, acetone, methanol, or acetonitrile. In a further embodiment, the polar solvent comprises dimethyl sulfoxide (DMSO), pyridine, or dimethylformamide (DMF). In another embodiment the method further comprises heating to a temperature between 40° C. to 100° C. In yet another embodiment, the method further comprises vacuum distillation to remove the solvent system and isolating the product of interest.
- In another aspect, the present invention provides a method for producing one or more compounds of formula (I), formula (II), formula (III), formula (IV) or formula (V) by an acid or base catalyzed trans-esterification reaction of an appropriate disaccharide with a suitable vinyl ester in a solvent system. In one embodiment, the base is potassium carbonate (K2CO3), sodium hydroxide (NaOH), or potassium hydroxide (KOH). In another embodiment, the acid is sulfuric acid (H2SO4) or hydrochloric acid (HCl). In a further embodiment, the vinyl ester comprises vinyl acetate, vinyl propionate, vinyl butyrate, vinyl cinnamate, vinyl methacrylate, vinyl oleate, vinyl linoleate, vinyl palmitate, or vinyl stearate. In another embodiment, the solvent system comprises a polar solvent such as dimethyl sulfoxide (DMSO), pyridine, or dimethylformamide (DMF).
- In another aspect, the present invention provides a method for producing one or more compounds of formula (VI) comprising reacting natural lactonic sophorolipid with formic acid or acetic acid under substantially non-aqueous conditions and partially or completely removing formate or acetate esters formed. In one embodiment, a second acid catalyzes the reaction of the natural sophorolipid with formic acid or acetic acid. In another embodiment, the second acid comprises sulfuric acid (H2SO4) or hydrochloric acid (HCl). In a further embodiment, the natural sophorolipid is produced by a fermentation host. In another embodiment, the fermentation host is Candida bombicola. In one embodiment, the substantially non-aqueous conditions comprise a reaction mixture having a water content of no more than about 10%. Another embodiment further comprises the step of heating at a temperature between 40° C. to 120° C. before the step of partially or completely removing the formate or acetate esters formed. In a further embodiment, the removal of the formate esters comprises refluxing in acetic acid and methanol. In another embodiment, the removal of the acetate esters comprises treating with an acid or a base.
- In another aspect, the present invention provides a method for producing one or more compounds of formula (VII) by a fermentation host. In one embodiment, the fermentation host is Candida bombicola. In another embodiment, the compounds of formula (VII) and (VIIa) are isolated from a crude mixture from a culture of Candida bombicola.
- In another aspect, the present invention provides a method for producing sophorose comprising reacting natural sophorosides with formic acid under substantially non-aqueous conditions and completely removing formate esters formed, wherein a purified sophorose is obtained. In one embodiment, the natural sophorosides are steviosides, sophorolipids, and flavonoid sophorosides. In another embodiment the step of reacting natural sophorosides with formic acid step is catalyzed by a second acid. In one embodiment, the second acid comprises sulfuric acid (H2SO4) or hydrochloric acid (HCl). In a further embodiment, the substantially non-aqueous conditions comprise a reaction mixture having a water content of no more than about 10%. In another embodiment, the method further comprises the step of heating at a temperature between 40° C. to 120° C. before the step of completely removing the formate esters. In a further embodiment, the step of completely removing the formate esters comprises treating with a base in a solvent. In one embodiment, the base is sodium methoxide (CH3NaO) or ammonia (NH3) and the solvent is methanol or ethanol.
- In another aspect, the present invention provides a compound having a structure of formula (II):
- wherein:
- Ra is H or C(O)R;
- Rb is H or C(O)R;
- Rc is H or C(O)R; and
- R is an aliphatic moiety, with the proviso that Rc is H when Ra is H or C(O)CH3 and Rb is H or C(O)CH3. In one embodiment, R is selected from the group consisting of unsubstituted C1-C24 alkyl; C1-C24 alkyl substituted with hydroxyl, carboxyl or aromatic groups; unsubstituted C2-C24 alkenyl; and C2-C24 alkenyl substituted with hydroxyl, carboxyl or aromatic groups. In another embodiment, R is an aliphatic moiety selected from unsubstituted C1-C24 alkyl, substituted C1-C24 alkyl, unsubstituted C2-C24 alkenyl, and substituted C2-C24 alkenyl. In a further embodiment, R is an aliphatic moiety selected from C1-C24 alkyl substituted with hydroxyl groups and C2-C24 alkenyl substituted with hydroxyl groups. In another embodiment, R is an aliphatic moiety selected from C1-C24 alkyl substituted with carboxyl groups and C2-C24 alkenyl substituted with carboxyl groups. In a further embodiment, R is an aliphatic moiety selected from C1-C24 alkyl substituted with aromatic groups and C2-C24 alkenyl substituted with aromatic groups.
- The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
-
FIG. 1 shows examples of carbohydrate esters for use as inducers for gene expression: (A) 6″ acetylated lactose monoester; (B) 6′ and 6″ acetylated alpha-sophorose diester; (C) 6′ and 6″acetylated maltose diester; (D) a deacetylated or 6′ and/or 6″ acetylated alpha-sophorose ester esterified at C-4″ position with an 18-carbon monounsaturated fatty alcohol hydroxylated at the C-17 position of the fatty alcohol chain; and (E) a deacetylated or 6′ and/or 6″ acetylated dimeric sophorolipid ester. In this figure, Rd=H or C(O)CH3; Re=H or C(O)CH3; Rf=H or C(O)CH3; and Rg=H or C(O)CH3. -
FIG. 2 shows examples of two additional compounds resulting from the formic acid treatment of lactonic sophorolipid containing a monounsaturated fatty acyl moiety: (A) sophorose ester with a 17-hydroxy fatty acyl group substituted with an additional hydroxyl at 9 position and (B) at 10 position. In this figure, Rd=H or C(O)CH3; Re=H or C(O)CH3; Rf=H or C(O)CH3; and Rg=H or C(O)CH3. -
FIG. 3 depicts a synthesis route for the preparation of carbohydrate esters: (A) preparation of lactose, cellobiose, maltose, and sophorose esters through chemical or enzymatically catalyzed trans-esterification; and (B) preparation of sophorolipid and dimeric sophorolipid ester through C. bombicola fermentation and preparation of sophorose and sophorose ester through formic acid treatment of sophorolipid followed by full and partial de-esterification, respectively. In this figure, Ra=H or C(O)R; Rb=H or C(O)R; Rc=H or C(O)R; Rd=H or C(O)CH3; Re=H or C(O)CH3; Rf=H or C(O)CH3; and Rg=H or C(O)CH3; and R is an aliphatic moiety. - The present invention relates to the chemical or biological modification of known carbohydrate inducers such as lactose, sophorose, and maltose in a cost effective manner that enhances their induction power in the production of industrially desirable proteins. The induction power of lactose, sophorose, and maltose is enhanced by several folds by modification to disaccharide esters, in particular as soluble monoesters, diesters, and triesters. Significantly improved yields of cellulase, amylase or other proteins under the control of a suitable promoter can be induced at higher yields than is currently possible. The present invention has the potential to significantly impact current enzyme production economics by improving both productivity and operations logistic in the manufacturing plant.
- The present invention also relates to a more effective method to produce novel and highly inductive sophorose esters from natural lactonic sophorolipid and the use of a novel, sophorolipid dimer ester compound as a highly potent inducer. Due to the ease of preparation of this new class of compounds, ready-to-use and industrially applicable inducers can be produced, which are also highly efficient and cost-effective. Furthermore, a more effective method of producing sophorose from natural sophorosides such as stevioside and sophorolipid is also described.
- Lactose, sophorose, cellobiose, maltose, or isomaltose monoester or diester compounds are produced by a trans-esterification reaction of unmodified disaccharide and a vinyl ester according to the method of the present invention.
FIGS. 1A through 1C depict three exemplary disaccharide monoacetates or diacetates that can be produced chemically or enzymatically from the trans-esterification reaction of a disaccharide and a vinyl acetate according to the method of the invention.FIG. 1A shows a lactose monoacetate ester, whileFIG. 1B depicts a sophorose diacetate ester.FIG. 1C shows a maltose diacetate ester. All three compounds are esterified at the 6′ and/or 6 position. - In another embodiment, sophorose esters are produced by the reaction of formic acid or acetic acid with natural lactonic sophorolipids under non-aqueous conditions resulting in a formyl- or acetyl-protected and C-1′ ring-opened sophorolipid. This is followed by partial or complete cleavage of the formate or acetate esters from the treated sophorolipid. Other side products, such as unmodified sophorolipids and higher esters (esters with DS>3), may also be present.
FIG. 1D depicts a deacetylated or 6′ and/or 6″ acetylated alpha-sophorose ester esterified at C-4″ position with an 18-carbon monounsaturated fatty alcohol hydroxylated at the C-17 position of the fatty alcohol chain. The compound was produced by formic acid reaction of natural diacetylated lactonic sophorolipid (obtained from the culture of C. bombicola) catalyzed by sulfuric acid followed by cleavage of formate ester from the treated parent compound by heating or refluxing the substrate in an acetic acid and methanol mixture. Sulfuric acid is an inexpensive and readily available catalyst. Formic acid can also participate in an addition reaction with lactonic sophorolipids that contain unsaturation on their fatty acyl moiety and may result in the formation of a hydroxyl group on the unsaturated positions upon the cleavage of formate ester. Two exemplary products are provided inFIG. 2 that result from the formic acid treatment of lactonic sophorolipid containing an 18-carbon fatty acyl moiety monounsaturated at 9 position.FIG. 2A andFIG. 2B depict a sophorolipid ester with a 17-hydroxy fatty acid substituted with an additional hydroxyl at 9-position and 10-position, respectively. - In another aspect, a sophorose dimer is produced by the yeast C. bombicola using the method of the invention. The compound may be isolated from the crude culture of C. bombicola where other side products may consist of natural acetylated lactonic or acidic sophorolipid.
FIG. 1E depicts a deacetylated or 6′ and/or 6″ acetylated sophorolipid dimer ester esterified at C-4″ position with an 18-carbon monounsaturated fatty chain. The compound is produced by fermentation of C. bombicola using glucose and canola oil as feedstock. - The lactose, sophorose, cellobiose, maltose, isomaltose esters, sophorose ester (obtained from formic acid treatment of natural lactonic sophorolipid), and the sophorolipid dimer produced by the method of the invention have the structures depicted by formula (I), (II), (III), (IV), (V), (VI), and (VII), respectively:
- where Ra is H or C(O)R;
- Rb is H or C(O)R;
- Re is H or C(O)R;
- Rd is H or C(O)CH3;
- Re is H or C(O)CH3;
- Rf is H or C(O)CH3;
- Rg is H or C(O)CH3; and
- R is an aliphatic moiety, with the proviso that in formula (II), Rc is H when Ra is H or C(O)CH3 and Rb is H or C(O)CH3.
- In some embodiments, R is an aliphatic moiety selected from unsubstituted C1-C24 alkyl, substituted C1-C24 alkyl, unsubstituted C2-C24 alkenyl, and substituted C2-C24 alkenyl.
- In other embodiments, R is an aliphatic moiety selected from C1-C24 alkyl substituted with hydroxyl groups and C2-C24 alkenyl substituted with hydroxyl groups.
- In further embodiments, R is an aliphatic moiety selected from C1-C24 alkyl substituted with carboxyl groups and C2-C24 alkenyl substituted with carboxyl groups.
- In certain embodiments, R is an aliphatic moiety selected from C1-C24 alkyl substituted with aromatic groups and C2-C24 alkenyl substituted with aromatic groups.
- In some embodiments, the esters produced by the method of the invention have the structures depicted by compounds of formula (Ia), (IIa), (IIIa), (IVa), (Va), (VIa), or (VIIa):
- where Rd is H or C(O)CH3; Re is H or C(O)CH3; Rf is H or C(O)CH3; and Rg is H or C(O)CH3.
- In a further embodiment, the sophorose ester is a novel compound having a structure of formula (II):
- wherein:
- Ra is H or C(O)R;
- Rb is H or C(O)R;
- Rc is H or C(O)R; and
- R is an aliphatic moiety, with the proviso that Rc is H when Ra is H or C(O)CH3 and Rb is H or C(O)CH3.
- As used herein, an “aliphatic” moiety is a non-aromatic carbon moiety. In some embodiments, an aliphatic moiety may include a linear, branched or cyclic carbon moiety. In certain embodiments, an aliphatic moiety may include a saturated or unsaturated moiety, including both monovalent and bivalent moieties. In some embodiments, the aliphatic moiety is an aliphatic alkyl, an aliphatic alkenyl, an aliphatic alkynyl, an aliphatic cycloalkyl, an aliphatic cycloalkenyl, an aliphatic cycloalkynyl, or any bivalent radicals thereof.
- “Alkyl” includes saturated linear or branched hydrocarbon structures, and combinations of these, which contain only carbon and hydrogen atoms when unsubstituted. In some embodiments, alkyl groups have one to twenty-four carbon atoms (i.e., C1-C24 alkyl), five to twenty-four carbon atoms (i.e., C5-C24 alkyl), or fifteen to eighteen carbon atoms (i.e., C15-C18 alkyl). When an alkyl residue having a specific number of carbon atoms is named, all geometric isomers having that number of carbon atoms may be encompassed. For example, “butyl” may, in some embodiments, include n-butyl, sec-butyl, iso-butyl, and tert-butyl; “propyl” may, in some embodiments, include n-propyl and iso-propyl. In some embodiments, the alkyl group may be substituted. In one embodiment, substituted alkyl groups may have a hydroxyl substituent. Alkyl groups substituted with hydroxyl may include, for example, —(CH2)2OH and —(CH2)4OH. In another embodiment, substituted alkyl groups may have a carboxyl substituent. Alkyl groups substituted with carboxyl may include, for example, —(CH2)2COOH. In another embodiment, substituted alkyl groups may have an aromatic substituent. Alkyl groups substituted with aromatic may include, for example, —CH2(phenyl).
- “Cycloalkyl” refers to a cyclic alkyl group, and can have one ring (e.g., cyclohexyl) or multiple rings (e.g., adamantyl).
- “Alkylene” refers to the same residues as alkyl, but having bivalency. Examples of alkylene include methylene (—CH2—), ethylene (—CH2CH2—), propylene (—CH2CH2CH2—), butylene (—CH2CH2CH2CH2—), as well as longer chains including —(CH2)17—.
- “Alkenyl” refers to an unsaturated hydrocarbon group having at least one site of olefinic unsaturation (i.e., having at least one moiety of the formula —C═C—). When the alkenyl has one site of olefinic unsaturation, the alkenyl is monounsaturated. When the alkenyl has two or more sites of olefinic unsaturation, the alkenyl is polyunsaturated. In some embodiments, alkenyl groups have two to twenty-four carbon atoms (i.e., C2-C24 alkenyl), five to twenty-four carbon atoms (i.e., C5-C24 alkenyl), or fifteen to eighteen carbon atoms (i.e., C15-C18 alkenyl). Alkenyl groups may include, for example, —CH2—CH═CH—CH3 and —(CH2)7—CH═CH—(CH2)7—CH3. In some embodiments, the alkenyl group may be substituted. In one embodiment, substituted alkenyl groups may have a hydroxyl substituent. Alkenyl groups substituted with hydroxyl may include, for example, —(CH2)2OH and —(CH2)4OH. In another embodiment, substituted alkenyl groups may have a carboxyl substituent. Alkenyl groups substituted with carboxyl may include, for example, —(CH2)2COOH. In another embodiment, substituted alkenyl groups may have an aromatic substituent. Alkenyl groups substituted with aromatic may include, for example, —CH2(phenyl).
- “Cycloalkenyl” refers to a cyclic alkenyl group and can have one ring (e.g., cyclohexenyl, —CH2—CH2-cyclohexenyl), or multiple rings (e.g., norbornenyl).
- “Alkenylene” refers to the same residues as alkenyl, but having bivalency. Examples of alkenylene include ethylene (—CH═CH—), propylene (—CH2—CH═CH—), butylene (—CH2—CH═CH—CH2—), as well as longer chains including —(CH2)7—CH═CH—(CH2)7— and —(CH2)7—CH═CH—(CH2)6—CH═CH—.
- Unless otherwise specified, the carbohydrate esters of the present invention depicted by structures with formula (I) through (VII) and (Ia) through (VIIa) have the following glycosidic linkages: formula (I), (Ia), lactose (gal(beta 1, 4)glc); formula (II), (IIa), sophorose (glc(beta 1, 2)glc); formula (III), (IIIa), cellobiose (glc(beta 1, 4)glc); formula (IV), (IVa), maltose (glc(alpha 1, 4)glc); formula (V), (Va), isomaltose (glc(alpha 1, 6)glc); formula (VI), (VIa), sophorose (glc(beta 1, 2)glc); and formula (VII), (VIIa), sophorose (glc(beta 1, 2)glc).
- One or more carbohydrate esters produced by the methods described herein, or any compositions thereof, can be used as inducers that cause cells to produce large amounts of enzymes or other substances than they would otherwise produce if the inducer were absent. Isolated and purified carbohydrate esters produced by the present methods may be used as inducers or the crude reaction mixture containing the carbohydrate esters may be used as an inducer without further purification.
- In one aspect, one or more of the carbohydrate esters produced by methods of the invention described herein, or any compositions thereof, can be used for inducing protein production (e.g., cellulase or amylase production) in fermentation host organisms capable of producing cellulase or amylase in a liquid culture containing an appropriate carbon source. For example, in certain embodiments, one or more carbohydrate esters with a structure of formula (I) through (VII), or any compositions thereof, can be used to induce protein production. Examples of such organisms include filamentous fungi, which have the ability to metabolize cellulose or starch by producing cellulases or amylase that can hydrolyze the beta-(1,4)-linked glycosidic bonds of cellulose or alpha-(1,4)-linked glycosidic bonds of starch to produce glucose.
- Suitable filamentous fungi may include all filamentous forms of the subdivision Eumycotina. (See, Alexopoulos, C. J. (1962), Introductory Mycology, Wiley, New York). These fungi are usually characterized by a vegetative mycelium with a cell wall composed of chitin, cellulose, and other complex polysaccharides. Suitable species of filamentous fungi or bacteria or other hosts for use with the carbohydrate ester inducers of the present invention include, for example, hosts selected from the following genera: Trichoderma, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces, Thermomonospora, Bacillus, Cellulomonas, Penicillium, Basidiomycete, Chrysoporium, Pestalotiopsis, Neurospora, Cephalosporium, Achlya, Podospora, Endothia, Mucor, Cochliobolus, Myceliopthora, Talaromyces and Pyricularia. Specific hosts may include, for example, Trichoderma reesei(QM 9414, MCG 77, MCG 80, Rut-C30, CL-847, VTT-D, SVG, and RL-P37) (see Esterbauer et al., Bioresource Tech., 36(1):51-65, (1991)), Aspergillus niger, Aspergillus oryzae, Bacillus subtilis, Penicillium decumbens, Penicillium funiculosum, Penicillium purpurogenum, Chrysosporium lucknowense, Myceliopthora thermophila, and Talaromyces emersonii.
- In some embodiments, one or more of the carbohydrate esters produced by the methods of the present invention, or any compositions thereof, are used to induce protein production (e.g., cellulase or amylase production) in a host cell that is a member of the species of Trichoderma, Penicillium, Chrysosporium, Humicola, Pleurotus, Fusarium, Aspergillus, Streptomyces, Thermomonospora, Myceliopthora, Talaromyces, Bacillus or Cellulomonas. In certain embodiments, one or more carbohydrate esters, or any compositions thereof, are used to induce protein production (e.g., cellulase or amylase production) in a host cell that is a member of the species of Trichoderma or Aspergillus. In one embodiment, one or more carbohydrate esters, or any compositions thereof, are used to induce protein production in Trichoderma reesei, Trichoderma viride, Aspergillus niger, or Aspergillus oryzae. The term “Trichoderma” refers to any fungal genus previously or currently classified as Trichoderma. In certain embodiments, the carbohydrate ester is one or more esters with a structure of formula ((I) through (VII), or preferably, structures of formula (Ia) through (VIIa).
- For industrial enzyme production, conventional inducers such as lactose, cellobiose, cellulose, cellulose hydrolysates, starch hydrolysate, and sophorose from glucose reversion are typically used to induce protein expression in Trichoderma reesei, while maltose, maltodextrins, starch, and starch hydrolysates are the inducers of choice for Aspergillus spp. In some case, these inducers may not perform optimally due to an insufficient amount or unintended repression by impurities or metabolites. Supplementing conventional inducers with the inducers disclosed herein may increase protein expression over that achievable with conventional inducers alone. Therefore, the use of the inducers of the invention may be useful either alone or in combination with each other or with conventional inducers.
- In one embodiment, induction of Trichoderma with lactose is augmented by the addition of the sophorose esters with structure shown in
FIG. 1D andFIGS. 2A and 2B . In another embodiment, induction of Trichoderma with a glucose reversion mixture containing sophorose is augmented by the addition of the sophorose esters with structure shown inFIG. 1D andFIGS. 2A and 2B . In yet another embodiment, induction of Trichoderma with a biomass hydrolysate (e.g., cellulose, starch) is augmented by the addition of the sophorose esters with structure shown inFIG. 1D andFIGS. 2A and 2B . In a further embodiment, induction of Aspergillus protein expression with maltose or maltodextrins is enhanced by supplementation of the inducer mixture with the maltose ester(s) with structures depicted by formula IV andFIG. 1C . - In another embodiment, sophorose esters with structures of formula II, VI, and VII may be used to induce enhanced protein production in solid phase fermentation. Production of enzymes and other protein products using solid phase fermentation relies on the growth of microbes (in particular, filamentous fungi) on moist solid substrates without free-flowing liquid. In contrast to liquid-submerged fermentation, solid phase fermentation in some situations can offer significant advantages in both performance and production cost. Suitable solid substrates include readily available and inexpensive carbon sources based on agriculture residues such as wheat bran or corn cobs, or mixtures thereof. Suitable filamentous fungi for use in this embodiment have been described above and include Trichoderma reesei and Aspergillus niger.
- The solid substrates are moistened with an appropriate nutrient medium to reach a starting moisture content of 40%, 50%, 60%, or 70% to allow the fungi to grow on the substrate. Prior to use, these solid substrates might be activated by pretreatment with steam and chemicals known to those skilled in the art. Crude or purified sophorose ester is mixed into the solid substrate and fermentation is initiated by inoculating the mixture with an appropriately prepared culture of a suitable filamentous fungi. The resulting product, for example, an enzyme such as cellulase is then isolated from the mixture by methods known in the art. Typical isolation involves washing the solid state fermentation media with a liquid. In some cases, the solid substrate might be pressed and/or a detergent might be added to the washing liquid to improve efficiency. In some applications (e.g., animal feed), the enzymes are not isolated and are used as produced together with the solid substrate.
- It should also be understood that the carbohydrate esters described herein, or any compositions thereof, may be used with genetically engineered host cells. To produce proteins with recombinant DNA technology, a DNA construct that includes the nucleic acid encoding the amino acid sequence of the designated protein can be constructed and transferred into, for example, a T. reesei, Aspergillus niger, or Aspergillus oryzae host cell. The vector may be any vector known in the art which, when introduced into the host cell, can be integrated into the host cell genome and can be replicated. The nucleic acid encoding the protein can be operably linked to a suitable promoter, which shows transcriptional activity in a Trichoderma or Aspergillus host cell. Suitable promoters may include, for example, cellobiohydrolase 1 (cbh1), endoglucanase, xylanase, glucoamylase A (glaA), and Taka-amylase (amyA). In one exemplary embodiment, the carbohydrate esters described herein with a structure of formula (I), (II), (III), (VI), (VII), or any compositions thereof, may be a powerful inducer of the cbh1 promoter in Trichoderma, which may increase cellulase production by several folds compared to other known cellulase inducers. In another exemplary embodiment, the carbohydrate esters described herein with structure of formula (IV), or (V), or any compositions thereof, may be a powerful inducer of the glaA or amyA promoter in Aspergillus, which may increase amylase production by several folds compared to other known amylase inducers.
- It should be understood, however, that the carbohydrate esters described herein, or any compositions thereof, may induce production of any protein that may be under the control of a native or engineered promoter, such as cbh1 or glaA. The promoter may be derived from genes encoding proteins that may be either homologous or heterologous to the host cell. One of skill in the art would recognize that a promoter can be engineered to enhance its function and the applicability of this new inducer should not be constrained by its alteration. Homologous or heterologous protein expression under this promoter may be routinely carried out using recombinant molecular biology techniques known in the art, which may rely on successful recombination of genes encoding the protein of interest. Examples of homologous and heterologous proteins of interest include, for example, enzymes, hormones, growth factors, cytokines, vaccines, antibodies, and polypeptides. In some embodiments, the carbohydrate esters described herein may induce production of enzymes including, for example, cellulases, amylases, proteases, xylanases, lipases, esterases, phytases, pectinases, catalases, pullulanases, laccases, oxidases, glucose isomerases, lyases, acylases, and transferases.
- Fermentation procedures for production of proteins are generally known to one of skill in the art. Generally, cells are cultured in a medium containing physiological salts and nutrients. (See, e.g., Pourquie, J. et al., Biochemistry and Genetics of Cellulose Degradation, Aubert, J. P. et al., eds., Academic Press, pp. 71-86, 1988; and Ilmen, M. et al., Appl. Environ. Microbiol., 63:1298-1306 (1997). For example, Trichoderma and Aspergillus cells may be cultured in the medium as described by England et al. (U.S. Published Patent Application No. 2010/0009408) and by Barton et al. (J. Bacteriol., 111(3):771-777 (1972), respectively. Culture-conditions (e.g., temperature, pH, duration) are also generally known in the art. For example, cultures may be incubated at approximately 28° C. in appropriate medium in shake cultures or fermenters until desired levels of cellulase expression are achieved. After fungal growth has been established, the cells are exposed to conditions effective to cause or permit the expression of the protein. An appropriate carbon source is also provided in the culture medium. Examples of appropriate carbon source biomass include, but are not limited to, glucose, sucrose, fructose, glycerol, lactose, cellulose, cellulose hydrolysate, starch, starch hydroylsate, maltose, or maltodextrin.
- One or more of the carbohydrate esters described herein, or any compositions thereof, may be added to the medium at a concentration effective to induce protein production (e.g., cellulase or amylase production). The esters may also be added to the medium in an insoluble or soluble form. In certain embodiments, the carbohydrate esters can be reconstituted in water or one or more solvents (e.g., ethanol, or dimethyl sulfoxide) prior to the introduction into the fermentation culture as a media component or as an inducing feed. Solubilizing the inducers allows for their use as a concentrated feed for protein production in an industrial fed-batch fermentation process. Further, it should be understood that the carbohydrate ester inducers may be used in a batch, fed-batch, or a continuous fermentation process.
- The use of one or more of the carbohydrate esters described herein has been found to surprisingly increase cellulase or amylase production by several folds compared to unmodified starting material such as lactose, sophorose, maltose, or natural sophorolipids. In certain embodiments, the use of one or more of carbohydrate esters, or any compositions thereof, can increase cellulase production in a Trichoderma host (e.g., T. reesei) or amylase production in Aspergillus host (e.g., Aspergillus niger) by at least three folds, by at least four folds, at least five folds, at least ten-fold, at least twenty-fold, or at least thirty-fold, greater than an unmodified lactose or sophorose. In certain embodiments, the carbohydrate esters are one or more esters with a structure of formula (I) through (VII), or preferably, with a structure of formula (Ia) through (VIIa).
- While the carbohydrate esters produced by methods of the present invention may be used to induce protein expression directly as a crude reaction mixture containing other side products, it should also be understood that the active carbohydrate ester components of the crude mixture can be individually separated or isolated, and optionally further purified. For example, in some embodiments, one or more esters with a structure of formula (I) through (VII), or preferably, with a structure of formula (Ia) through (VIIa), may be isolated for use in protein production. In some embodiments, the use of purified lactose monoester or sophorose diester isolated from the crude ester mixture may result in at least a one-fold, at least a two-fold, or at least a three-fold increase in cellulase production in Trichoderma compared to the use of an unpurified crude mixture. It should be understood that the unmodified lactose or sophorose is the one from which the lactose and sophorose esters were prepared.
- The embodiments in the specification are selected to best explain the principles of the invention and its practical use under the described conditions that might not be optimized. One of skill in the art would recognize the induction power of these novel inducers may be enhanced by variations in process conditions and by the alterations made to the production host. The applicability of this invention should not be constrained by these variations.
- Provided herein are methods of producing lactose, sophorose, cellobiose, maltose, and isomaltose esters by enzymatic or chemically catalyzed trans-esterification of unmodified disaccharides with a vinyl ester. Several methods are currently known in the art for esterifying carbohydrates including, for example, chemical or enzymatic synthesis of sucrose esters (Polat and Linhardt, J. Surfact. Deterg., 4(4):415-421 (2001)), enzymatic synthesis of a maltose monolaurate ester (Plou et al., J. Biotech., 96:55-66 (2002)) and a lactose monolaurate ester (U.S. Patent Application Publication No. 2011/0257108), and chemical synthesis of a maltose monostearate (Allen and Tao, J. Surfact. Deterg., 5(3):245-255 (2002)).
- One or more compounds of formula (I) through (V) are prepared by: a) providing a disaccharide such as lactose, sophorose, cellobiose, maltose, or isomaltose, preferably dry and preferably in high purity; and b) contacting the disaccharide with a vinyl ester and an enzyme or chemical catalyst in a suitable solvent system to produce the composition. In some embodiments, the reaction mixture is heated to a temperature of 40° C. to 100° C. In other embodiments, the acid hydrolysis may be performed at a temperature of at least 40° C., at least 50° C., at least 60° C., at least 70° C., at least 80° C., at least 90° C., or at least 100° C. In yet another embodiment, the method for producing a composition that includes one or more compounds of formula (I) through (V), further includes vacuum distillation to remove the solvent; and isolating the product of interest from the composition.
- Vinyl esters may be fatty acid vinyl esters or aromatic vinyl esters. Suitable fatty acid vinyl esters include vinyl acetate, vinyl propionate, vinyl butyrate, vinyl methacrylate, vinyl oleate, vinyl linoleate, vinyl palmitate, and vinyl stearate. Examples of aromatic vinyl esters include vinyl cinnamate and vinyl caffiate.
- Suitable lipase enzymes for use in the method of the present invention include Novozyme 435 (immobilized Candida antarctica lipase B), Lipozyme® TL, Lipozyme® RM, and Amano lipase PS.
- In some embodiments, the enzyme catalyst can be replaced with a chemical catalyst (e.g., potassium carbonate (K2CO3), sodium hydroxide (NaOH), sulfuric acid (H2SO4), and hydrochloric acid (HCl)) and the vinyl ester can be replaced with acyl chlorides (e.g., acetyl chloride or palmitoyl chloride).
- Suitable solvents include dimethyl sulfoxide (DMSO), pyridine, dimethylformamide (DMF), methyl ethyl ketone, isobutanol, tert-amyl alcohol, tert-butyl alcohol, tetrahydrofuran, acetone, or mixtures thereof.
- In one aspect, the methods described herein involve enzymatically or chemically modifying disaccharides by trans-esterification reaction with a vinyl ester. These modified disaccharide esters are highly inductive to protein production (e.g., cellulase or amylase production) in filamentous fungi host cells (e.g., Trichoderma or Aspergillus), exceeding the inductive ability of unmodified starting materials by several folds.
- The methods described herein typically yield a crude mixture consisting of active carbohydrate ester as component(s). Any separation techniques known in the art may be employed to isolate the active esters, for example, vacuum distillation, precipitation, crystallization, solvent extraction, or column chromatography.
- One skilled in the art will recognize many variations can be made following the spirit of the invention. In certain embodiments, other disaccharides and soluble polysaccharides may be modified into potent inducers using the same principles disclosed in this invention. Examples of other disaccharides include sucrose, trehalose, gentiobiose, laminaribiose, and xylobiose. Examples of polysaccharides include cellodextrins and maltodextrins.
- Provided herein are also methods for producing novel and highly inductive sophorose esters with a structure of formula of (VI) by formic acid or acetic acid reaction with natural lactonic sophorolipid under substantially non-aqueous conditions followed partial or complete cleavage of formate or acetate esters from the formyl- or acetyl-protected and C-1′ lactone ring-opened sophorolipid. In order to obtain a compound with a structure of formula of (VI), a natural lactonic sophorolipid needs to be ring-opened through selective cleavage of the ether-like linkage at the C-1 (the anomeric carbon) position, followed by regeneration of the hydroxyl group of the hydroxy fatty acid, which remains linked by an ester bond to C-4″ (as shown in
FIG. 1D ). Previously described methods for this transformation are limited by the low yields obtained. The inventor disclosed the use of 0.1N hydrochloric acid with natural sophorolipid under aqueous conditions to produce these compounds (International application no.: WO 2013/003291). The present invention comprises a high yield method involving the reaction of formic or acetic acid with natural lactonic sophorolipid carried out under non-aqueous conditions. This new method promotes cleavage of the ether-like linkage (C-1′) in preference to the ester linkage (C-4″) of the natural lactonic sophorolipid, thus resulting in a high yield. Unintended formate and acetate esters may be formed with the open hydroxyls during the formic acid or acetic acid treatment of sophorolipid, which require cleavage in order to yield compounds described by formula (VI). - The formic acid or acetic acid reactions may be catalyzed by another acid. Examples of suitable acid catalyst include, for example, sulfuric acid (H2SO4) or hydrochloric acid (HCl), or mixtures of acid catalysts, at a concentration (wt %) between about 0.05% to about 1%. Appropriate concentrations include 0.05%, 0.10%, 0.15%, 0.20%, 0.30%, 0.50%, 0.75%, and 1%. The natural lactonic sophorolipid may be produced by a fermentation host, including, but not limited to, C. bombicola. Substantially non-aqueous conditions may comprise a water content of no more than about 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or less than 1%, by weight.
- In some embodiments, the acid treatment is performed at elevated temperatures. The formic acid and acetic acid treatment may be characterized as a formolysis and an acetolysis reaction, respectively. In certain embodiments, the formolysis or acetolysis may be performed at a temperature of at least 40° C. In other embodiments, the formolysis or acetolysis may be performed at a temperature of at least 80° C., at least 90° C., at least 100° C., at least 110° C. or at least 120° C. In other embodiments, the formolysis or acetolysis may be performed at a temperature between 40° C. and 120° C., or between 100° C. and 120° C. The natural sophorolipid mixture can be contacted with the acid at elevated temperatures for a range of time, e.g., from minutes to hours.
- In one embodiment, the cleavage of formate ester from the lactone ring-opened sophorolipid involves heating or refluxing the starting material in an acetic acid and methanol mixture. For example, the ratio of acetic acid to methanol may be 3:2 (v/v). In another embodiment, the cleavage of acetate esters involves treating the starting material with an acid, for example, HCl, or a base, for example, ammonia, or an enzyme, for example, esterase. The cleavage of the formate or the acetic ester from the treated sophorolipid may be partial. Migration of fatty and acetyl acyl groups may occur during the cleavage. Further, the lactonic sophorolipid containing single or multiple unsaturation on its fatty acid acyl moiety may participate in an addition reaction with formic acid at the unsaturated positions and the cleavage of formate esters may result in the formation of the hydroxyl group on the unsaturated positions in cases where the sophorose ester contains mono or polyunsaturated fatty acid moieties, for example, in compounds of described in
FIG. 2 . One of skill in the art would recognize that a partial cleavage of formate and acetate ester, acyl migrations, and hydroxylation of unsaturation may result in new compounds that may be equal to or more inductive than the compounds with structures depicted by (VI). The applicability of this method is not be constrained by this variation. - In another embodiment, the natural lactonic sophorolipid may be first pretreated with formic anhydride or acetic anhydride to yield a compound that is protected by formic and/or acetic esters on all open hydroxyls. This is then followed by the formic and acetic acid treatment to selectively cleave the sophorolipid lactone ring at the C-1′ anomeric position and followed by the partial or complete cleavage of formic and acetic ester from the hydroxyls. One of skill in the art would recognize this pretreatment may result in a significant increase in yield with an improved selectivity at the C-1′ anomeric position.
- In yet another embodiment, the natural laconic sophorolipid may be first pretreated with a hydrogenation reaction to remove potential unsaturations on its fatty acyl group (e.g., monounsaturated 17-hydroxy oleic acid, diunsaturated 17-dihydroxy linoleic acid). One of skill in the art would recognize that this pretreatment may result in a significant reduction in side products being produced, with the final product primarily consisting of a sophorose ester with a saturated fatty acyl group. A more convenient work up may also result from the hydrogenation pretreatment.
- Provided herein is also a method for using sophorolipid dimer described by formula (VII) as a highly potent inducer. This compound was recently described by Price et al. (Carbohyd. Res., 348:33-41 (2012), although Price et al. did not recognize its potential in gene induction. In contrast to other known natural sophorolipids (e.g. acetylated and deacylated lactonic or acidic sophorolipids), even if the dimeric sophorolipid exists in trace amounts, it is surprisingly inductive to gene expression in Trichoderma, as described herein. Suitable fermentation hosts for the sophorolipid dimer include, for example, C. bombicola. Examples of an appropriate feedstock for this fermentation method comprises glucose and a vegetable oil, including, but not limited to, canola, soybean, corn, or palm oil. In certain embodiments, compounds of formula (VII) may be isolated as a crude mixture from the culture of Candida bombicola, and still possess surprisingly strong inductive effects.
- Also provided herein is a method of producing sophorose by reacting formic acid with natural sophorosides under non-aqueous conditions, followed by complete cleavage of unwanted formate esters. Several low yield methods are currently known in the art that include direct synthesis (Coxon and Fletcher, J. Org. Chem., 26(8):2892-2894 (1961)), acetic acid and hydrobromic acid reaction with stevioside octacacetate followed by deacetylation (Vis and Fletcher, J. Am. Chem. Soc., 78:4709-4710 (1956)), and a dilute hydrochloric acid treatment of stevioside followed by purification (Kusakabe et al., Agric. Biol. Chem., 51(8):2255-2256 (1987)).
- The present invention describes a simple method of using formic acid reacting with natural sophorosides under non-aqueous conditions followed by cleavage of unwanted formate ester that gives an improved yield of sophorose. In one aspect, a sophoroside is any compound that consists of sophorose as one of its component. Examples of sophorosides include stevioside, sophorolipids and flavonoid sophorosides. In one embodiment, the formic acid reactions may be catalyzed by another acid. Examples of suitable acid catalyst include sulfuric acid (H2SO4) and hydrochloric acid (HCl), or mixtures of acid catalysts, at a concentration (wt %) between about 0.05% to about 1%. Appropriate concentrations include 0.05%, 0.10%, 0.15%, 0.20%, 0.30%, 0.50%, 0.75%, and 1%.
- In one embodiment, the sophoroside is a sophorolipid is produced from a fermentation host, including, but not limited to, C. bombicola. The substantially non-aqueous conditions may comprise a water content of no more than about 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, or less than 1%, by weight.
- In some embodiments, the formic acid treatment is performed at elevated temperatures. In certain embodiments, the formic acid formolysis may be performed at a temperature of at least 40° C. In other embodiments, the formolysis may be performed at a temperature of at least 80° C., at least 90° C., at least 100° C., at least 110° C. or at least 120° C. In other embodiments, the formolysis may be performed at a temperature between 40° C. and 120° C., or between 100° C. and 120° C. The natural sophorolipid mixture can be contacted with the formic acid at elevated temperatures for a range of time, e.g., from minutes to hours.
- In one embodiment, the cleavage of formate esters from the treated sophoroside involves treating the reaction mixture with a base in a solvent. Examples of suitable base include, but are not limited to, sodium methoxide (CH3NaO) and ammonia (NH3). Examples of suitable solvents include, but are not limited to, methanol, ethanol, and 1-propanol.
- In another embodiment, the sophorosides may be first pretreated with formic anhydride or acetic anhydride to yield a compound that is protected by formic and/or acetic esters on all open hydroxyls. This pretreatment is then followed by the formic acid treatment to selectively cleave the sophorosides at the C-1′ anomeric position, followed by complete cleavage of formic and acetic ester from the hydroxyls. One of skill in the art would recognize this pretreatment may result in a significant increase in yield of sophorose due to an improved selectivity at the C-1′ anomeric position.
- In yet another embodiment, the formic acid treatment of a sophoroside based on natural lactonic and/or acidic sophorolipid may be carried out first after a hydrogenation reaction to remove potential unsaturations on its fatty acyl group. One of skill in the art would recognize this pretreatment may result in a significant reduction in side products being produced and a more convenient work up for sophorose is expected as a result of the hydrogenation pretreatment of the sophorolipids.
- Sophorose may be isolated and purified from the final reaction mixture through methods known in the art. Suitable purification methods include, for example, chromatography, adsorption, extraction, precipitation, re-precipitation, crystallization, and recrystallization.
- The afore-mentioned natural lactonic sophorolipid mixture and sophorolipid dimers may be prepared from microbial cultures using yeast. Suitable yeast strains may be selected from, for example, the following genera: Candida, Starmerella, Rhodotorula, and Wickerhamiella. Specific strains suitable for sophorolipid production include, for example, C. bombicola (e.g., ATCC 22214, NRRL Y-30816), Starmerella bombicola, Candida apicola, Candida riodocensis, Candida stellata, and Candida sp. NRRL Y-27208. (See Kurtzman et al., FEMS Microbiol. Lett., 311:140-146 (2010)).
- In some embodiments, the natural sophorolipid mixture is produced by the yeast C. bombicola or Candida apicola. For example, C. bombicola has an active extracellular lipase system that first cleaves triglycerides from vegetable oil into free fatty acids, which are readily taken up by the yeast. The fatty acids then undergo hydroxylation at the ultimate or penultimate carbon through the action of cytochrome P450. Sophorose is then added onto the hydroxylated fatty acid by the actions of two glycosyltransferases. (See Fleurackers, Eur. J. Lipid Sci. Technol., 108: 5-12, (2006)). Acetylation and lactonization complete the formation of sophorolipids, which are then secreted by the yeast.
- Fermentation procedures for production of sophorolipids are generally known to one of skill in the art. Suitable carbon substrates used in the fermentation to produce the natural sophorolipids may include hydrophobic substrates, for example, vegetable oils (e.g., canola, soy, corn, palm, coconut, sunflower seed, cottonseed, or olive oils), fatty acids (e.g., palmitic, oleic, elaidic, linoleic, alpha-inolenic, or stearic acids), fatty acid esters (e.g., fatty acid methyl ester or fatty acid ethyl ester), alkanes (e.g., pentadecane, hexadecane, heptadecane, or octadecane), and fatty alcohols (e.g., pentadecanol, hexadecanol, heptadecanol, or octadecanol).
- The length of the carbon substrates used in the fermentation to produce the natural sophorolipids generally depend on the fermentation host. For example, in certain embodiments where a Candida host (e.g., C. bombicola) is used, the fatty acids and/or alkanes have a chain length of between fifteen and eighteen carbon atoms. In one variation, fatty acids with carbon chains of between fifteen and eighteen carbon atoms may be preferable to alkanes with carbon chains of between fifteen and eighteen carbon atoms. (See Van Bogaert et al., Process Biochem., 46(4): 821-833 (2011)). In one embodiment, the carbon substrate used in the fermentation to produce the natural sophorolipids is canola oil, which has a high C$ content and a monounsaturated fatty acid chain. Further, it should also be understood that other longer or shorter carbon substrates can be used, but can be reduced or elongated to between 15 and 18 carbon-member chains for use with a Candida host.
- Yeast typically produces a mixture of sophorolipids, and the sophorolipid molecules of the mixture usually have one sophorose molecule linked to a hydroxylated fatty acid at the C-1′ position of the sophorose molecule. The natural sophorolipid mixture may include diacetylated sophorolipids in either lactonic or acidic forms. For natural sophorolipid mixtures produced by C. bombicola, diacetylated lactonic sophorolipids are typically present in a greater amount (e.g., greater than 60%) than acidic sophorolipids (e.g., less than 10%). See Asmer et al., J. Am. Oil Chem. Soc., 65(9):1460-1466 (1988); Davila et al., J. Chromatography, 648:139-149 (1993); Davila et al., J. Indust. Microbio., 13: 249-257 (1994); Ratsep & Shah, J. Microbio. Methods, 78:54-356 (2009). The sophorolipids of the natural sophorolipid mixture typically have acetyl groups at the C-6″ and/or C-6′ positions of the sophorose molecule. See Van Bogaert et al., Process Biochemistry 46(4):821-833 (2011). The fatty acid groups may be saturated or unsaturated, and may vary in length. Typically, sophorolipids in a natural sophorolipid mixture have a fatty acid chain of sixteen to eighteen carbon atoms.
- The composition of the natural sophorolipid mixture may depend on the type of feedstock and culture conditions. For example, if the feedstock is a fatty acid ester rather than vegetable oil or free fatty acids, more of the free acidic sophorolipids may be produced. (See Ashby et al., U.S. Published Patent Application No. 2006/0199244.) On the other hand, if an alkane such as hexadecane or heptadecane is used, more of the actonic sophorolipids are produced. (See Glenns and Cooper, J. Am. Oil Chemist Soc., 83(2):137-145 (2006).)
- The following examples are intended only to further illustrate the invention and are not intended to limit the scope of the invention as defined by the claims.
- This example describes the preparation of the lactose acetate esters depicted in
FIG. 1A from lactose using enzyme-catalyzed trans-esterification, which enhances their protein induction power in Trichoderma. - The preparation starts first with dissolving 25 mg of D-lactose (Sigma-Aldrich) with 0.20 mL of dimethyl sulfoxide (DMSO) in a 20 mL glass scintillation vial. This was followed with the addition of 1.8 mL of tert-amyl alcohol, 0.125 g of molecular sieve (SYLOSIV, WR Grace, Columbia, Md.), and 0.125 g of immobilized lipase enzyme (Lipozyme TL, Novozymes, Franklinton, N.C.). The mixture was pre-incubated inside a shaker incubator at 50° C. and 150 RPM for 1 hour after which 0.142 mL vinyl acetate (Sigma-Aldrich, St. Louis, Mo.) was added to initiate the trans-esterification reaction. The reaction was allowed to progress for 16 hours inside the shaker incubator at 50° C. and 150 RPM.
- At the end of the reaction, the crude product mixture was removed from the scintillation vial and recovered as the supernatant via centrifugation where the solvents were evaporated using a SpeedVac concentrator (Savant, Thermo Scientific). For NMR and induction studies, the lactose monoacetate was fractionated from the crude mixture by flash chromatography. A 5 g self-packed silica gel (Fisher, 230-400Mesh) column was used with an eluent (1-propanol:ethyl acetate:water, 4:5:1) with isocratic elution.
- The purity of the lactose monoacetate ester was confirmed via LC-MS using a Waters 2695 HPLC with Waters ZQ 2000 Mass spectrometer and a Waters 2487 UV detector. The analysis was conducted using a Waters Symmetry C18 column (4.6×250 mm, 5 μm) with a (5%/95%) acetonitrile and water eluent containing 0.1% formic acid as the mobile phase run isocratically for a total run time of 15 minutes.
- To prepare for protein induction studies using Trichoderma, a citrate minimal media was first prepared. The media composition, as modified from England et al. (U.S. Pat. No. 7,713,725), consists of 14.4 g/L citric acid, 4 g/L KH2PO4, 6.35 g/L (NH4)2SO4, 2 g/L MgSO4-7H2O, 0.53 g/L CaCl2-2H2O, and trace metal elements at 1 mL/L comprising 5 g/L FeSO4-7H2O, 1.6 g/L MnSO4—H2O, and 1.4 g/L ZnSO4-7H2O. The final pH was adjusted to 5.50 using NaOH. T. reesei Rut-C30, a cellulase hyper-secretor, was selected as the host to test for protein expression. It was obtained from ATCC (56765) and developed as a catabolic de-repressed strain from classic mutagenesis of parent strain NG14 and the wild type QM6A (Seidl et al., BMC Genomics, 9:327, (2008)). To propagate Trichoderma, the freeze-dried stock from ATCC was first dissolved in sterile deionized water and then transferred onto a PDA (potato dextrose agar) plate (Teknova P0047) using a sterile loop. The PDA plate was maintained at room temperature under white fluorescent light and after approximately 7 days, green Trichoderma spores could be seen. In addition, 60% (w/v) glucose stock was prepared and used both as control and as the carbon source for Trichoderma growth.
- To initiate protein induction studies, 0.5 mL of glucose stock was first placed into 14 mL of citrate minimal media inside a 125 mL baffled flask, followed by the addition of 0.5 mL of prospective inducer. For the glucose (no inducer) control, 0.5 mL of glucose stock was placed into 14.5 mL minimal media to give a final glucose concentration of 2%. To commence the fermentation, an approximately 1 cm by 1 cm square agar plug was removed from the Trichoderma spore-containing PDA agar plate using a sterile loop and placed into the protein induction culture media to be tested. The cultures were placed inside a 28° C. incubator with shaking at 175 RPM. At day 3 of fermentation, the samples were collected and analyzed for CMC (carboxymethylcellulose) endo-glucanase activity. Since the T. reesei Rut-C30 is a cellulase hyper-producer, the CMC activity directly correlates with the amount of protein being induced. The CMC activity assay follows a procedure modified from Mandels and Reese with a 0.3 mL reaction volume (J. Bacteriol., 73:269-278, (1957)). One CMC unit denotes the activity that liberates 1 μmol of reducing sugars (expressed as glucose equivalents) in one minute under specified conditions of 50° C. and pH 4.8.
- The results for CMC activity assays are given in Table 1, which shows the cellulase activity of known inducers versus the enzymatically prepared crude lactose acetate ester mixture and purified lactose monoacetate. The crude lactose monoacetate mixture, containing both lactose monoacetate and lactose diacetate, is already very powerful and highly efficient. At 0.8 g/L, it easily surpasses the induction power of lactose and cellobiose at 1.0 g/L. Its specific induction power (expressed as units U/mg inducer) is 14 times higher than unmodified lactose.
-
TABLE 1 Inducer Cellulase concentration activity mg/15 U/mL U/mg Induction media* mL mM at day 3 at day 3 glucose control (2%) 0 0 0.28 ± 0.17 NA lactose (1.0 g/L) 15 2.92 0.64 0.64 cellobiose (1.0 g/L) 15 2.92 0.34 0.34 sophorose (0.13 g/L) 2.0 0.38 3.58 26.9 sophorose (1.3 g/L) 20 3.90 15.0 11.2 Crude lactose acetate 12 NA 7.07 8.84 mixture (0.80 g/L) Purified lactose monoacetate 1.4 0.23 2.05 22.0 (0.09 g/L) Purified lactose monoacetate 7.6 1.32 10.1 19.9 (0.51 g/L) Purified lactose monoacetate 15.8 2.73 14.0 13.3 (1.05 g/L) *All media contain 2% glucose as carbon source. - Even though the impure crude lactose ester mixture is highly inductive, an equivalent mass of the purified lactose monoacetate is even more powerful. The specific induction activity of lactose monoacetate at 0.09 g/L, 0.51 g/L, and 1.05 g/L, measured at day 3, is approximately 34, 31, and 21 times that of unmodified lactose, respectively. Furthermore, the specific induction power of the lactose monoacetate at 0.09 g/L (22.0 U/mg) nearly approaches that of sophorose (26.9 U/mg), which is currently the gold standard for cellulase induction in Trichoderma.
- The purified lactose monoacetate was confirmed by LC-MS to contain a molar mass of 384 (402 [M+NH4]+ and 407 [M+Na]+). The structure of the lactose monoacetate was further confirmed by analysis using nuclear magnetic resonance (NMR; Varian 400 mHz).
- Based on the spectra of H NMR, 13C-NMR, and two dimensional 13C—H HSQC NMR, the lactose monoacetate as depicted in
FIG. 1A was confirmed to be an α and β anomer mixture of lactose monoacetylated at 6″ position. The assignments of protons and carbons for the isolated lactose monoacetate fraction are summarized in Table 2 below. -
TABLE 2 Functional 13C—NMR 1H—NMR groups δ(ppm) δ(ppm) Lactose 1′ α: 92.57 α: 4.89 β: 97.21 β: 4.32 2′ α: 72.68 α: 3.17 β: 75.07 β: 2.96 3′ α: 71.83 α: 3.59 β: 75.19 β: 3.30 4′ α: 81.89 3.27 β: 81.44 5′ α: 70.23 α: 3.70 β: 75.38 β: 3.30 6′ α: 61.05 3.63, 3.72 β: 61.10 1″ α: 104.17 4.26 β: 104.09 2″ α: 70.86 3.34 β: 70.80 3″ α: 73.38 3.36 β: 73.41 4″ α: 68.83 3.62 5″ 72.90 3.74 6″ 64.04 4.08, 4.18 Acetyl group —C═O 170.91 CH3 21.28 2.02 - This example shows that sophorose acetate esters can be prepared from sophorose through enzyme-catalyzed trans-esterification, which enhances its protein induction power in Trichoderma. The preparation of crude sophorose ester mixture, purified sophorose diacetate, and the subsequent induction study followed the procedure described in Example 1 except the amount of vinyl acetate used was 0.026 mL.
- The CMC activity results shown in Table 3 compare the protein induction power of the crude sophorose acetate ester mixture and purified sophorose diacetate ester to that of sophorose. The crude mixture even though impure is already highly efficient and powerful and at 0.17 g/L. Its specific induction power at 70.2 U/mg is ˜3 times that of unmodified sophorose. The purified sophorose diacetate ester is even more powerful and at 0.12 g/L. Its specific induction power at 193.3 U/mg is ˜7_times that of unmodified sophorose.
-
TABLE 3 Cellulase activity Inducer concentration U/mL U/mg Induction media* mg/15 mL mM at day 3 at day 3 glucose control (2%) 0 0 0.28 ± 0.17 NA sophorose (0.13 g/L) 2.0 0.38 3.58 26.9 sophorose (1.3 g/L) 20 3.90 15.0 11.2 Crude sophorose acetate 2.5 NA 11.7 70.2 mixture (0.17 g/L) Purified sophorose 1.8 0.28 23.2 193.3 diacetate (0.12 g/L) *All media contain 2% glucose as carbon source. - The crude sophorose acetate mixture was analyzed by LC-MS using the same procedure described in Example 1 and was found to consist of a mixture of sophorose monoacetate with a mass of 384 (402 [M+NH4]+), diacetate with a mass of 426 (444 [M+NH4]+), and unreacted sophorose. From the LC-MS, the purity of purified sophorose diacetate ester was confirmed.
- This example shows that sophorose palmitate belonging to the structure class with formula (II) can be prepared from sophorose through enzyme-catalyzed trans-esterification to further enhance its protein induction power in Trichoderma.
- The preparation of crude sophorose palmitate ester mixture and the subsequent induction study followed the procedure described in Example 1 except that 5 mg of sophorose was used as the substrate and vinyl palmitate (TCI America, Portland, Oreg.) was used instead of vinyl acetate. Further purification of the crude product mixture was not carried out.
- The CMC activity results shown in Table 4 compare the protein induction power of the crude sophorose palmitate mixture to that of sophorose. The crude mixture, even though impure, is already highly efficient and powerful at 0.17 g/L. Its specific induction power at 73.8 U/mg is similar to the crude sophorose acetate mixture (Table 3) and is ˜3 times that of unmodified sophorose.
-
TABLE 4 Cellulase activity Inducer concentration U/mL U/mg Induction media* mg/15 mL mM at day 3 at day 3 glucose control (2%) 0 0 0.28 ± 0.17 NA sophorose (0.13 g/L) 2.0 0.38 3.58 26.9 sophorose (1.3 g/L) 20 3.90 15.0 11.2 Crude sophorose 2.5 NA 12.3 73.8 palmitate mixture (0.17 g/L) *All media contain 2% glucose as carbon source. - The crude sophorose monopalmitate mixture was analyzed by LC-MS using the same procedure described in Example 1 except a mobile phase of (70%/30%) acetonitrile and water containing 0.1% formic acid was used and the purification was run isocratically for a total run time of 30 minutes. The sample was found to consist of a mixture of monopalmitates with a molar mass of 580 (603 [M+Na]+) and dipalmitates with a mass of 818 (841 [M+Na]+).
- This example shows that lactose acetate ester can be also prepared from lactose through chemically-catalyzed trans-esterification to enhance its protein induction power in Trichoderma.
- The procedure starts first with preparing a 0.4 M lactose solution in dimethyl sulfoxide (DMSO). The solution (2 mL) was mixed with 3 mg of potassium carbonate (K2CO3) catalyst and preheated at 50° C. for 30 minutes to activate the catalyst. After removing undissolved catalyst, the reaction was initiated by adding vinyl acetate with differing molar ratios (vinyl acetate: lactose) in order to control the degree of substitution. Each reaction had a volume of 200 μL and was heated to 60° C. for 30 minutes using a thermocycler without stirring. The subsequent sample recovery and induction study followed the procedure described in Example 1.
- The results for CMC activity assays are given in Table 5. The crude lactose acetate ester mixture prepared at a vinyl acetate to lactose ratio of 2:1 gave highest induction. It is very powerful and highly efficient compared to cellobiose and lactose. At 0.91 g/L, it easily surpasses the induction power of lactose and cellobiose at 1.0 g/L. Its specific induction power (expressed as units U/mg inducer) is 13 times higher than unmodified lactose and similar to the enzymatically prepared crude lactose acetate mixture (Table 1).
-
TABLE 5 Inducer Cellulase activity concentration U/mL U/mg Induction media* mg/15 mL mM at day 3 at day 3 glucose control (2%) 0 0 0.28 ± 0.17 NA lactose (1.0 g/L) 15 2.92 0.64 0.64 cellobiose (1.0 g/L) 15 2.92 0.34 0.34 sophorose(0.13 g/L) 2.0 0.38 3.58 26.9 sophorose(1.3 g/L) 20 3.90 15.0 11.2 Crude lactose acetate mixture 13.6 NA 5.66 6.24 (0.91 g/L) (Vinyl acetate:Lactose 4:1) Crude lactose acetate mixture 13.6 NA 7.37 8.13 (0.91 g/L) (Vinyl acetate:Lactose 2:1) Crude lactose acetate mixture 13.6 NA 6.58 7.26 (0.91 g/L) (Vinyl acetate:Lactose 1:1) Crude lactose acetate mixture 13.6 NA 6.21 6.85 (0.91 g/L) (Vinyl acetate:Lactose 1:2) Crude lactose acetate mixture 13.6 NA 3.89 4.29 (0.91 g/L) (Vinyl acetate:Lactose 1:4) *All media contain 2% glucose as carbon source. - Based on LC-MS analysis, the crude lactose acetate mixture, prepared chemically with a varying vinyl acetate to lactose ratio, consists of a mixture of acetates with multiple degree of substitution. At high vinyl acetate to lactose ratio (e.g. 4:1), majority are triacetates and diacetates while at lower ratio (e.g. 1:4), majority are monoacetates and unmodified lactose. A ratio of 2:1 gave the highest induction, yielding a product consisting of mainly mono, di, and triacetate esters.
- This example shows that sophorose acetate esters can be also prepared from sophorose through chemically-catalyzed trans-esterification and how they can be further purified to enhance their protein induction power in Trichoderma. The procedure of preparing sophorose acetate esters chemically follows the same procedure described in Example 4 and subsequent sample recovery and induction study followed the procedure detailed in Example 1 except the crude mixture was further purified based on procedure described in Example 1 to isolate the sophorose diacetate ester.
- The results for CMC activity assays are shown in Table 6. The crude sophorose acetate ester mixture, prepared at a vinyl acetate to sophorose ratio of 1:1, gave highest induction. It is very powerful and highly efficient and greatly exceeds the unmodified sophorose. At 0.09 g/L, its specific induction power (expressed as units U/mg inducer) is 5 times higher than unmodified sophorose and the crude mixture is further purified to isolated sophorose diacetate ester and its specific induction is ˜8 times higher than unmodified sophorose.
-
TABLE 6 Inducer Cellulase activity concentration U/mL U/mg Induction media* mg/15 mL mM at day 3 at day 3 glucose control (2%) 0 0 0.28 ± 0.17 NA sophorose (0.13 g/L) 2.0 0.38 3.58 26.9 sophorose (1.3 g/L) 20 3.90 15.0 11.2 Crude sophorose acetate mixture 2 NA 15.4 115.5 (0.13 g/L) (Vinyl acetate:Sophorose 4:1) Crude sophorose acetate mixture 2 NA 17.7 132.8 (0.13 g/L) (Vinyl acetate:Sophorose 2:1) Crude sophorose acetate mixture 2 NA 18.1 135.8 (0.13 g/L) (Vinyl acetate:Sophorose 1:1) Crude sophorose acetate mixture 1.37 NA 13.4 147.0 (0.09 g/L) (Vinyl acetate:Sophorose 1:1) Crude sophorose acetate mixture 1.37 NA 9.45 103.5 (0.09 g/L) (Vinyl acetate:Sophorose 1:2) Crude sophorose acetate mixture 1.37 NA 7.68 84.1 (0.09 g/L) (Vinyl acetate:Sophorose 1:4) Purified sophorose diacetate 0.45 0.07 6.33 211.0 (0.03 g/L) *All media contain 2% glucose as carbon source. - Based on LC-MS analysis, the crude sophorose acetate mixture, prepared chemically with a varying vinyl acetate to sophorose ratio, consists of a mixture of acetates with multiple degree of substitution. At high vinyl acetate to sophorose ratio (e.g. 4:1), the products are mainly tri-, tetra-, penta-, and hexa-acetates, while at lower ratio (e.g. 1:4), the products are mainly are di- and mono-acetates and unmodified sophorose. The ratio of 1:1 gave the highest induction, and the majority of the products are mono-, di-, and tri-acetate esters.
- The purified sophorose diacetate ester was confirmed by LC-MS to contain a molar mass of 426 (444 [M+NH4]+ and 449 [M+Na]+). The structure of the sophorose diacetate was further confirmed by analysis using nuclear magnetic resonance (NMR; Varian 400 mHz).
- Based on the spectra of 1H NMR, 13C-NMR, and two dimensional 13C-1H HSQC NMR, the sophorose diacetate as depicted by
FIG. 1B was confirmed to be an alpha-sophorose diester acetylated at both 6′ and 6″ position. The assignments of protons and carbons for the isolated sophorose acetate fraction are summarized in Table 7 below. -
TABLE 7 Functional groups 13C—NMR δ (ppm) 1H—NMR δ (ppm) Sophorose 1′ 91.6 5.06 1 105.1 4.32 2′ 82.1 3.19 2 73.7 3.06 3′ 71.3 3.64 3 76.0 3.14 4′ 70.0 3.16 4 70.1 3.11 5′ 68.9 3.77 5 73.4 3.36 6′ a, 6″ a 63.6, 63.9 4.02 6′ b, 6″ b 4.23 Acetyl group —C═O 170.3 CH3 (6′) 20.7 2.00 CH3 (6″) 20.7 2.01 - This example shows that maltose acetate ester can be also prepared from maltose through chemically-catalyzed trans-esterification to enhance its protein induction power in Aspergillus. The procedure of preparing maltose acetate chemically and subsequent sample recovery follows the same procedure described in Example 4. To prepare for protein induction studies using Aspergillus, a minimum media was first prepared with 1 g/L KH2PO4, 2 g/L NH4Cl, 0.5 g/L MgSO4-7H2O, 0.2 mg/L CuSO4-5H2O, 12.5 mg/L FeSO4-7H2O, 1 mg/L ZnSO4-7H2O, and 0.09 mg/L MnSO4 . Aspergillus niger (NRRL 330), obtained from ARS culture collection, was maintained on a PDA plate and allowed to sporulate for a week at room temperature. For inoculation, a 2 cm by 2 cm area agar plug was first removed and suspended in 5 mL sterile water. The spores were washed off from agar with vigorous agitation and 1 mL of the suspension was used as inoculum with 14 mL media and 1% sorbitol as carbon source in a 125 mL baffled flask. The cultures were allowed to progress inside a shaker incubator (28° C. and 200 RPM) for 2 days at which time the inducer was added. After additional 24 hours, the cultures were assayed for amylase activity following similar procedures to those detailed by Barton et al. (J. Bacteriol., 1972, 111(3):771-777).
- The results for amylase activity assays are shown in Table 8. The crude maltose acetate ester mixture prepared at a vinyl acetate to maltose ratio of 2:1 gave highest induction. It is more powerful and highly efficient compared to maltose. At 0.05 g/L, its specific induction power (138.1 U/mg) is 3 times higher than unmodified maltose (44.0 U/mg).
-
TABLE 8 Inducer Amylase activity concentration U/mL U/mg Induction media* mg/15 mL mM at day 3 at day 3 Maltose control (0.05 g/L) 0.72 0.14 2.11 44.0 Crude maltose acetate mixture 0.72 NA 3.64 75.8 (0.05 g/L) (Vinyl acetate:maltose 4:1) Crude maltose acetate mixture 0.72 NA 6.63 138.1 (0.05 g/L) (Vinyl acetate:maltose 2:1) Crude maltose acetate mixture 0.72 NA 6.03 125.6 (0.05 g/L) (Vinyl acetate:maltose 1:1) Crude maltose acetate mixture 0.72 NA 5.66 117.9 (0.05 g/L) (Vinyl acetate:maltose 1:2) *All media contain 1% sorbitol as carbon source. - Based on LC-MS analysis, the crude maltose acetate mixture, prepared chemically with a varying vinyl acetate to maltose ratio, consists of a mixture of acetates with multiple degree of substitutions. At high vinyl acetate to maltose ratio (e.g. 4:1), the product is mainly tri-, tetra-, penta-, and hexa-acetates, while at a lower ratio (e.g. 1:2), the product is mainly tri-, di-, and mono-acetates and unmodified maltose. The ratio of 2:1 gave the highest induction, and the product is mainly mono-, di-, and tri-acetate esters.
- This example describes a highly effective method of using formic acid to convert non-inductive natural lactonic sophorolipid into novel and highly inductive sophorose esters with structures described by
FIG. 1D andFIG. 2 . To prepare natural lactonic sophorolipid, C. bombicola (ATCC 22214) was used. A sample of freeze-dried stock in a glass vial was obtained from ATCC and was first transferred into a yeast extract, peptone, dextrose (YPD) culture broth, then allowed to grow for 48 hours at 28° C. for two days. The culture was then mixed with sterilized glycerol to prepare a final culture containing 20% glycerol. A cell bank was then established using cryovials with 1 mL of seed culture each, and stored at −80° C. - For the production of natural sophorolipids from canola oil, a production medium was first prepared and included the following components: 100 g/L glucose, 10 g/L yeast extract, 1 g/L urea, and 100 g/L canola oil (Crisco, The J.M. Smucker Company, Orrville, Ohio). Based on the data provided from the manufacturer, the canola oil has 64% monounsaturated fat from mainly oleic fatty acid, and 29% polyunsaturated fat from mainly linoleic and alpha-linolenic fatty acids. To initiate the fermentation, a 1 mL seed of C. bombicola from a cryovial as prepared above was placed into 50 mL of production medium inside a 250 mL baffled flask incubated at 28° C. and 250 revolutions per minute (RPM). After seven days, sophorolipids appeared in the media as a viscous brown oily phase, and in some cases, the sophorolipid crystallized into a yellow to white colored residue. The brown oily sophorolipid was isolated using a separation funnel and further purified to recover diacetylated lactonic sophorolipids using a self-packed silica gel column (Fisher, 230-400 Mesh) eluted isocractically using ethyl acetate. To recover crystalline sophorolipids consisting of mostly diacetylated lactonic sophorolipid, sophorolipids were allowed to stand until sediment formed, which was recovered by decanting and washing with water followed by freeze drying. The purity of harvested samples was confirmed by the result from LC-MS and found be a diacetylated lactonic sophorolipid derivatized with hydroxy oleate fatty groups with a molar mass of 688 (706 [M+H2NH4]+ and 711 [M+Na]+).
- The next step was treatment with formic acid. The process began by dissolving 5 mg diacetylated lactonic sophorolipid in 200 μL formic acid. In certain runs, this step was followed by addition of 0.31 μL (0.15%) of concentrated sulfuric acid. The reaction mixture was heated to 80° C. in a thermocycler for 30 minutes without stirring. Water (1 mL) was then added to precipitate the sample, followed by centrifugation to recover the precipitate and drying in a SpeedVac to remove residual water and formic acid. The dried sample was then solubilized in 200 μL acetic acid to methanol (3:2 v/v) solution and heated to 90° C. for 6 hours to cleave unwanted formate ester from the treated sophorolipid. This step was followed with another drying step using a SpeedVac to remove acetic acid and methanol. The final samples, which were a crude mixture of products, were tested for induction in Trichoderma following the procedure described in Example 1.
- The CMC activity results shown in Table 9 compare the protein induction power of the crude sophorose ester obtained from the formic acid treatment of natural lactonic sophorolipid to other known inducers. The tested samples, even though impure, were highly efficient and powerful compared to known inducers. The natural diacetylated lactonic sophorolipid is not inductive relative to the glucose control and, after formic acid treatment, its specific induction at 0.33 g/Lis enhanced 52-fold. If 0.15% sulfuric acid is used together with formic acid, the specific induction is enhanced by as much as 487-fold at a concentration of 0.03 g/L. Even as an impure, crude sample, the specific induction power of the mixture at 496.5 U/mg is 18 times that of sophorose, the current best in class inducer.
-
TABLE 9 Cellulase activity Inducer concentration U/mL U/mg Induction media* mg/15 mL mM at day 3 at day 3 glucose control (2%) 0 0 0.28 ± 0.17 NA lactose (1.0 g/L) 15 2.92 0.64 0.64 cellobiose (1.0 g/L) 15 2.92 0.34 0.34 sophorose (0.13 g/L) 2.0 0.38 3.58 26.9 sophorose (1.3 g/L) 20 3.90 15.0 11.2 Untreated diacetylated 5 0.48 0.34 1.02 lactonic sophorolipid (0.33 g/L) Formic acid treatment 5 NA 17.7 53.1 (0.33 g/L) Formic acid +0.15% 5 NA 29.5 88.5 sulfuric acid treatment (0.33 g/L) Formic acid +0.15% 2.5 NA 29.3 175.8 sulfuric acid treatment (0.17 g/L) Formic acid +0.15% 1 NA 22.7 340.5 sulfuric acid treatment (0.07 g/L) Formic acid +0.15% 0.5 NA 16.6 496.5 sulfuric acid treatment (0.03 g/L) *All media contain 2% glucose as carbon source. - This example illustrates that the natural sophorolipid dimer depicted in
FIG. 1E , can also serve as a highly efficient inducer for gene expression in Trichoderma. A crude sample containing the sophorolipid dimer was prepared from the cultures of C. bombicola according the procedures described in Example 7 and was typically harvested as a brown oily residue. In addition to canola oil, soybean and corn oil were also used as feedstock (Crisco, The J.M. Smucker Company, Orrville, Ohio). In most cases, the C. bombicola yeast did not produce the dimeric sophorolipid. In a few cases, a trace amount was produced and its presence was revealed by LC-MS, which showed molar masses of 1030, 1028, 1072, 1070, 1114, and 1112 (1053[M+Na]+, 1051[M+Na]+, 1095[M+Na]+, 1093[M+Na]+, 1137[M+Na]+, and 1135[M+Na]+, respectively). The molar masses 1030 and 1028 denote a diacetylated sophorolipid dimer derivatized with an oleate or a linoleate fatty group, respectively. The molar masses 1072 and 1070 denote a triacetylated dimer derivatized with an oleate or a linoleate fatty group, respectively. The molar masses of 1114 and 1112 denote a tetra-acetylated dimer derivatized with an oleate or a linoleate fatty group, respectively. These dimeric compounds were not further isolated, and induction studies were carried out using crude samples following the procedures described in Example 1. - The CMC activity results shown in Table 10 compare the protein induction power of the crude sophorolipid dimer mixture obtained from C. bombicola culture to other known inducers. The crude samples, even though impure as shown by LC-MS and TLC, are highly efficient and powerful comparing to known inducers. The crude sample that does not contain dimers is significantly less inductive than samples containing dimers. At 0.90 g/L, the specific induction (19.7 U/mg) of the sample containing dimer grown on canola oil is 7 times the induction produced by the sample without dimer and nearly approaches that of sophorose (26.9 U/mg). Since these dimers exist as only trace amounts in the crude sample, purified dimeric compounds once isolated may be even more powerful.
-
TABLE 10 Inducer Cellulase activity concentration U/mL U/mg Induction media* mg/15 mL mM at day 3 at day 3 glucose control (2%) 0 0 0.28 ± 0.17 NA lactose (1.0 g/L) 15 2.92 0.64 0.64 cellobiose (1.0 g/L) 15 2.92 0.34 0.34 sophorose (0.13 g/L) 2.0 0.38 3.58 26.9 sophorose (1.3 g/L) 20 3.90 15.0 11.2 Crude sample without dimers 16 NA 2.90 2.72 grown on canola oil (1.07 g/L) Crude sample containing dimers 12.5 NA 16.4 19.7 grown on canola oil (0.90 g/L) Crude sample containing dimers 12.5 NA 14.5 17.4 grown on soybean oil (0.90 g/L) Crude sample containing dimers 12.5 NA 15.5 18.6 grown on corn oil (0.90 g/L) *All media contain 2% glucose as carbon source. - In order to be most useful in commercial applications, sophorose needs to become cheaper and more readily available. This example provides a simple and effective method to produce sophorose in high yield from formic acid treatment of natural sophoroside (stevioside and sophorolipid) under non-aqueous conditions. The procedure is similar to that described in Example 7, except that the samples were freeze dried after formic acid treatment and then solubilized in 0.5 M sodium methoxide in methanol for 15 minutes at room temperature. This process removes unwanted formate or fatty esters to produce sophorose. After another drying step using a SpeedVac to remove methanol, the sample was analyzed by HPLC (Waters 2695, 401 RI detector, and BioRad HPX-87H column) to determine the sophorose concentration. As a comparison, stevioside was treated with 0.1 N hydrochloric acid to yield sophorose following the procedure detailed by Kusakabe et al. (Agric. Biol. Chem., 1987, 51(8):2255-2256).
- The results in Table 11 show that when compared with the dilute hydrochloric acid treatment described by Kusakabe, the formic acid treatment produces a significantly increased yield. Using stevioside as a starting material, the yield of sophorose tripled using the formic acid treatment. Using diacetylated lactonic sophorolipid as a starting material, the yield of sophorose was doubled when the formic acid treatment was supplemented with addition of 0.15% sulfuric acid.
-
TABLE 11 Theoretical Recoverable Sophoroside Treatment sophorose sophorose Yield 5 mg 0.1N HCl, 1.91 mg 0.353 mg 18.5% stevioside 100° C., 2 hr 5 mg Formic acid, 1.91 mg 1.08 mg 56.5% stevioside 80° C., 30 min 5 mg Formic acid +0.15% 1.91 mg 1.07 mg 56.0% stevioside sulfuric acid, 80° C., 30 min 5 mg Formic acid, 2.4 mg 0.449 mg 20.0% diacetylated 80° C., 30 min lactonic sophorolipid 5 mg Formic acid +0.15% 2.4 mg 0.861 mg 38.4% diacetylated sulfuric acid, lactonic 80° C., 30 min sophorolipid - Production of enzymes and other protein products using solid phase fermentation relies on the growth of microbes (in particular, filamentous fungi) on moist solid substrates without free-flowing liquid. In contrast to liquid-submerged fermentation, solid phase fermentation in some situations can offer significant advantages in both performance and production cost. This example demonstrates that sophorose ester with structures described by
FIG. 1D andFIG. 2 can be used as a very effective inducer for cellulase production in solid phase fermentation using T. reesei. - The solid substrate used was a 1:1 blend of wheat bran and corn cob purchased from local pet supply store. Each run consisted of 8 grams of this blend placed into a 125 mL flask, which was then sterilized by autoclaving. The citrate minimum media (pH 4.8) described in Example 1 was then added. The amounts of citrate media added were 5.3 mL, 8 mL, 12 mL, 18.7 mL, which gave a starting moisture content of 40%, 50%, 60%, and 70%, respectively. The sophorose ester used was a crude mixture obtained from the formic acid treatment of the natural lactonic sophorolipid (Example 7). For each run, crude sophorose ester (10 mg) premixed with citrate minimum media was then mixed into the solid substrate. Fermentation was initiated by mixing a 2 mL inoculum of T. reesei preculture (from day 2, Example 1) into the solid substrate followed by incubating the flasks at 28° C. without shaking. The solid sample from each flask was harvested at day 3 and washed with ten volumes of 50 mM citrate buffer (pH 4.8) and analyzed for CMC activity as described in Example 1.
- The results in Table 12 show that regardless of the starting moisture content, the addition of sophorose ester inducer to the solid substrate was able to significantly improve the cellulase production in the solid phase fermentation using T. reesei. At 40%, 50%, 60%, and 70% starting moisture, the observed improvements in cellulase activity per gram solid substrate are 4 fold, 7 fold, 12 fold, and 5 fold, respectively.
-
TABLE 12 Induction media Cellulase activity at day 3 (wheat bran:corn cob, 1:1) (U/g solids) 40% moisture control 7.40 40% moisture +10 mg sophorose ester 27.6 50% moisture control 3.37 50% moisture +10 mg sophorose ester 22.2 60% moisture control 1.78 60% moisture +10 mg sophorose ester 21.6 70% moisture control 5.45 70% moisture +10 mg sophorose ester 24.6 - While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
Claims (62)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/100,496 US20210079438A1 (en) | 2012-07-20 | 2020-11-20 | Carbohydrate esters as inducers for gene expression |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261673997P | 2012-07-20 | 2012-07-20 | |
US201261746120P | 2012-12-27 | 2012-12-27 | |
PCT/US2013/051147 WO2014015179A1 (en) | 2012-07-20 | 2013-07-18 | Carbohydrate esters as inducers for gene expression |
US201514414957A | 2015-01-15 | 2015-01-15 | |
US16/020,429 US10870873B2 (en) | 2012-07-20 | 2018-06-27 | Method of using carbohydrate esters as inducers for gene expression |
US17/100,496 US20210079438A1 (en) | 2012-07-20 | 2020-11-20 | Carbohydrate esters as inducers for gene expression |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/020,429 Continuation US10870873B2 (en) | 2012-07-20 | 2018-06-27 | Method of using carbohydrate esters as inducers for gene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210079438A1 true US20210079438A1 (en) | 2021-03-18 |
Family
ID=49949255
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/414,957 Active US10059973B2 (en) | 2012-07-20 | 2013-07-18 | Carbohydrate esters as inducers for gene expression |
US16/020,429 Active 2033-12-15 US10870873B2 (en) | 2012-07-20 | 2018-06-27 | Method of using carbohydrate esters as inducers for gene expression |
US17/100,496 Abandoned US20210079438A1 (en) | 2012-07-20 | 2020-11-20 | Carbohydrate esters as inducers for gene expression |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/414,957 Active US10059973B2 (en) | 2012-07-20 | 2013-07-18 | Carbohydrate esters as inducers for gene expression |
US16/020,429 Active 2033-12-15 US10870873B2 (en) | 2012-07-20 | 2018-06-27 | Method of using carbohydrate esters as inducers for gene expression |
Country Status (5)
Country | Link |
---|---|
US (3) | US10059973B2 (en) |
EP (1) | EP2875143A4 (en) |
CN (4) | CN104471071B (en) |
BR (1) | BR112014032940A2 (en) |
WO (1) | WO2014015179A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014205115A2 (en) | 2013-06-19 | 2014-12-24 | The Regents Of The University Of California | Regioselective silyl exchange of per-silylated oligosaccharides |
EP3320106A1 (en) * | 2015-07-07 | 2018-05-16 | Danisco US Inc. | Induction of gene expression using a high concentration sugar mixture |
CN107254002A (en) * | 2017-08-01 | 2017-10-17 | 张振 | Nano-cellulose containing cinnamyl functional groups and its preparation method and application |
CN109030815B (en) * | 2018-06-26 | 2021-08-10 | 安徽医科大学 | Protein chip for detecting liquid phase protein interaction and preparation method and application thereof |
CN108707595B (en) * | 2018-07-03 | 2021-07-27 | 华东理工大学 | Method for improving yield of cellulase produced by fungi |
CN109651456B (en) * | 2018-12-31 | 2020-07-28 | 京山瑞生制药有限公司 | Preparation method of sucrose oleate with high monoester content |
CN111172214A (en) * | 2020-01-16 | 2020-05-19 | 广州嘉德乐生化科技有限公司 | Maltotriase ester and preparation method and application thereof |
CN114106807B (en) * | 2020-08-27 | 2023-05-05 | 中国石油化工股份有限公司 | Modified sophorolipid composition, preparation method and application thereof |
CN113151373B (en) * | 2021-03-09 | 2023-07-04 | 武汉臻治生物科技有限公司 | Preparation method and application of sucrose monoester with antibacterial and antitumor activities |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200403321A (en) * | 2000-04-05 | 2004-03-01 | Honeywell Int Inc | Novel polymer/substrate and polymer/polymer interfaces and methods of modeling and forming same |
WO2010135588A2 (en) * | 2009-05-21 | 2010-11-25 | Verenium Corporation | Phytases, nucleic acids encoding them and methods for making and using them |
US8148108B2 (en) * | 2007-03-30 | 2012-04-03 | The University Of Akron | Process for producing cellulase |
CN102470160A (en) * | 2009-07-24 | 2012-05-23 | 利普泰股份公司 | Compounds which inhibit muscle contraction |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4818816A (en) | 1981-04-28 | 1989-04-04 | Choay, S.A. | Process for the organic synthesis of oligosaccharides and derivatives thereof |
DE19518982A1 (en) * | 1995-05-29 | 1996-12-05 | Hoechst Ag | Novel glucose and sophoroselipids, a process for their preparation and their use |
FR2735979B1 (en) | 1995-06-28 | 1997-08-14 | Inst Francais Du Petrole | USE AS THERAPEUTICALLY ACTIVE SUBSTANCES OR COSMETIC PRODUCTS OF SOPHOROLIPIDS, PARTICULARLY FOR THE TREATMENT OF THE SKIN |
DE19749413A1 (en) | 1997-11-07 | 1999-05-12 | Hoechst Ag | Novel sophorose lipids, process for their preparation and use |
DK1545217T3 (en) | 2002-09-10 | 2013-06-03 | Genencor Int | Induction of gene expression using a high concentration sugar mixture |
WO2007073371A1 (en) * | 2004-12-22 | 2007-06-28 | Polytechnic University | Sophorolipids as protein inducers and inhibitors in fermentation medium |
CN101166423B (en) | 2005-04-29 | 2015-03-25 | 阿克伦大学 | Affinity foam fractionation for collection and purification of materials |
US8664373B2 (en) * | 2008-10-28 | 2014-03-04 | Kaneka Corporation | Method for producing sophorose lipid |
US8323931B2 (en) | 2008-11-03 | 2012-12-04 | Iogen Energy Corporation | Hosts and fermentation processes for cellulase production |
CN101497633B (en) * | 2009-03-10 | 2011-04-27 | 南京师范大学 | Method for preparing isosteviol and sophorose at the same time |
WO2013003291A2 (en) | 2011-06-25 | 2013-01-03 | Tom Tao Huang | Chemically modified sophorolipids and uses thereof |
-
2013
- 2013-07-18 CN CN201380037346.2A patent/CN104471071B/en active Active
- 2013-07-18 EP EP13820206.4A patent/EP2875143A4/en not_active Withdrawn
- 2013-07-18 CN CN201710225917.5A patent/CN106977558B/en active Active
- 2013-07-18 BR BR112014032940A patent/BR112014032940A2/en not_active IP Right Cessation
- 2013-07-18 WO PCT/US2013/051147 patent/WO2014015179A1/en active Application Filing
- 2013-07-18 US US14/414,957 patent/US10059973B2/en active Active
- 2013-07-18 CN CN201710227094.XA patent/CN107011391B/en active Active
- 2013-07-18 CN CN201710225915.6A patent/CN107012188B/en active Active
-
2018
- 2018-06-27 US US16/020,429 patent/US10870873B2/en active Active
-
2020
- 2020-11-20 US US17/100,496 patent/US20210079438A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200403321A (en) * | 2000-04-05 | 2004-03-01 | Honeywell Int Inc | Novel polymer/substrate and polymer/polymer interfaces and methods of modeling and forming same |
US8148108B2 (en) * | 2007-03-30 | 2012-04-03 | The University Of Akron | Process for producing cellulase |
WO2010135588A2 (en) * | 2009-05-21 | 2010-11-25 | Verenium Corporation | Phytases, nucleic acids encoding them and methods for making and using them |
CN102470160A (en) * | 2009-07-24 | 2012-05-23 | 利普泰股份公司 | Compounds which inhibit muscle contraction |
Non-Patent Citations (3)
Title |
---|
English Machine Translation of CN 102470160 A, published on May 23, 2012, obtained from Espacenet on September 9, 2022 (https://worldwide.espacenet.com/) (Year: 2012) * |
English Machine Translation of TW 200403341 A, published on March 1, 2004, obtained from Espacenet on September 9, 2022 (https://worldwide.espacenet.com/) (Year: 2004) * |
Znameroski et al. "Induction of lignocellulose-degrading enzymes in Neurospora crassa by cellodextrins", PNAS, 2012, Vol. 109, No. 16, pp. 6012-6017; available April 2, 2012 (Year: 2012) * |
Also Published As
Publication number | Publication date |
---|---|
CN106977558B (en) | 2020-06-09 |
CN107011391B (en) | 2020-05-22 |
CN106977558A (en) | 2017-07-25 |
EP2875143A4 (en) | 2015-12-30 |
US20180327804A1 (en) | 2018-11-15 |
US10059973B2 (en) | 2018-08-28 |
EP2875143A1 (en) | 2015-05-27 |
CN107011391A (en) | 2017-08-04 |
US10870873B2 (en) | 2020-12-22 |
CN107012188A (en) | 2017-08-04 |
WO2014015179A1 (en) | 2014-01-23 |
CN104471071B (en) | 2021-05-28 |
CN107012188B (en) | 2020-10-30 |
BR112014032940A2 (en) | 2017-06-27 |
CN104471071A (en) | 2015-03-25 |
US20150152462A1 (en) | 2015-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210079438A1 (en) | Carbohydrate esters as inducers for gene expression | |
Liu et al. | Bioconversion of crude glycerol to glycolipids in Ustilago maydis | |
US9828592B2 (en) | Chemically modified sophorolipids and uses thereof | |
Shabtai et al. | Production, purification, and properties of a lipase from a bacterium (Pseudomonas aeruginosa YS-7) capable of growing in water-restricted environments | |
CN110835606A (en) | Fusarium oxysporum strain and methods of making and using same | |
US4959459A (en) | Surface active compounds and a process for their preparation | |
CN107624129B (en) | Inducible trichoderma reesei promoter | |
Imura et al. | Enzymatic conversion of diacetylated sophoroselipid into acetylated glucoselipid: surface-active properties of novel bolaform biosurfactants | |
JP5997479B2 (en) | Method for synthesizing sugar fatty acid esters by enzymatic method | |
Gulati et al. | Novel biocatalytic esterification reactions on fatty acids: synthesis of sorbitol 1 (6)-monostearate | |
Huang et al. | New-to-nature sophorose analog: a potent inducer for gene expression in Trichoderma reesei | |
Puchart et al. | Simultaneous production of endo-β-1, 4-xylanase and branched xylooligosaccharides by Thermomyces lanuginosus | |
Langer et al. | Production and modification of bioactive biosurfactants | |
JP3370670B2 (en) | Process for the enzymatic production of α-glucosides and α-glucoside esters and the use of the products thus obtained | |
Ertan et al. | Solid state fermentation for the production of α-amylase from Penicillium chrysogenum using mixed agricultural by-products as substrate | |
Iftikhar et al. | Production potential of locally isolated strain of Fusarium solani (MBL 24) for extracellular lipases | |
WO2018114995A1 (en) | Fermentation process for producing steviol glycosides | |
RU2397247C1 (en) | Lipase biosynthesis method | |
KR101716879B1 (en) | Method Producing Daptomycin Using Decanoyl Glyceride | |
Matsumura et al. | One-step preparation of alkyl β-D-glucosaminide by the transglycosylation of chitosan and alcohol using purified exo-β-D-glucosaminidase | |
Sembayeva et al. | Lipase-mediated regioselective modifications of macrolactonic sophorolipids | |
Bousquet et al. | Enzymatic synthesis of alkyl-α-glucoside catalysed by a thermostable α-transglucosidase in solvent-free organic medium | |
Saritha et al. | Glycoside hydrolase production by Aspergillus terreus CM20 using mixture design approach for enhanced enzymatic saccharification of alkali pretreated paddy straw | |
Riva | Enzymatic synthesis of carbohydrate esters | |
Riva et al. | Sugar transformations using enzymes in non-aqueous media |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |